EurekaMag PDF full texts Chapter 34,480

Hosoi, J.; Ozawa, H.; Granstein, R.D. 1999: Beta-endorphin binding and regulation of cytokine expression in langerhans cells. Luger, Thomas A [Author], Paus, Ralf [Author], Lipton, James M [Author], Slominski, Andrzej T [Author] Annals of the New York Academy of Sciences; Cutaneous neuroimmunomodulation: The proopiomelanocortin system 405-413

Taddio, A.; Shah, V.; Shah, P.; Katz, J. 2002: Beta-endorphin concentration after administration of sucrose in preterm infants. Pediatric Research 51(4 Part 2): 467A-468A

Jamurtas, A.Z.; Goldfarb, A.H.; Chung, S.C.; Hegde, S.; Marino, C. 1999: Beta-endorphin infusion during exercise Effects on glucose, FFAs and catecholamines. Medicine and Science in Sports and Exercise 31(5 Suppl): S267

Jamurtas, A.Z.; Goldfarb, A.H.; Chung, S.C.; Hegde, S.; Marino, C.; Fatouros, I. 2000: Beta-endorphin infusion effects on hepatic and muscle glycogen during exercise in rats. Medicine and Science in Sports and Exercise 32(5 Suppl): S224

Bohm, M.; Li, Z.; Ottaviani, M.; Picardo, M.; Zouboulis, C.C.; Stander, S.; Luger, T.A. 2004: Beta-endorphin modulates lipogenesis in human sebocytes. Journal of Investigative Dermatology 123(2)

Dokur, M.; Boyadjieva, N.; Advis, J.P.; Sarkar, D.K. 2003: Beta-endorphin perfusion in the paraventricular nucleus of the hypothalamus on perforin, Granzyme B and IFN-gamma gene expression Effects of ethanol. Alcoholism Clinical and Experimental Research 27(5 Suppl): 38A

Cosgrove, D.J. 2004: Beta-expansins as cell wall loosening agents, compositions thereof and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Lin, Y.h Meei 2004: Beta-fluoroethyl thiourea compounds and use. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)

Yanai, K.; Nakane, A.; Kono, T. 2003: Beta-fructofuranosidase and gene thereof. Official Gazette of the United States Patent and Trademark Office Patents 1270(3)

Yanai, K.; Nakane, A.; Nakamura, H.; Baba, Y.; Watabe, A.; Hirayama, M. 2002: Beta-fructofuranosidase and its gene, method of isolating beta-fructofuranosidase gene, system for producing beta-fructofuranosidase, and beta-fructofuranosidase variant. Official Gazette of the United States Patent and Trademark Office Patents 1254(2)

Ito, T.; Fujita, K.; Hara, K.; Tonozuka, T.; Sakano, Y. 2001: Beta-fructofuranosidase gene. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)

Ward, S.J.; Martin, T.J.; Roberts, D.C.S. 2002: Beta-funaltrexamine microinjected into the ventral tegmental area decreases cocaine self-administration under a progressive-ratio schedule of reinforcement. Drug and Alcohol Dependence 66(Suppl 1): S190-S191

Hackett, S.F.; Ozaki, H.; Strauss, R.; Wahlin, K.; Suri, C.; Maisonpierre, P.; Yancopoulos, G.; Campochiaro, P.A. 2000: Beta-galactosidase driven by the Angiopoietin-2 promoter is constitutively expressed predominantly in horizontal cells and is upregulated in association with retinal neovascularization. IOVS Investigative Ophthalmology and Visual Science 41(4): S141

Feld, B.; Nelson, A.; Miller, S.; Smythe, R.; Farquhar, D. 2002: Beta-galactoside prodrugs for use in conjunction with gene-directed enzyme prodrug therapy. Proceedings of the American Association for Cancer Research Annual Meeting 43: 944

Yamamoto, T.; Nakashizuka, M.; Terada, I. 2001: Beta-galactoside-alpha2, 6-sialyltransferase gene. Official Gazette of the United States Patent and Trademark Office Patents 1248(1)

Mondragon, M.C.; Cuellar Ambrosi, F.; Bedoya, G.; Bortolini, M.C.; Ruiz Linares, A. 2000: Beta-globin gene cluster haplotype frequencies in Colombia suggest different origins for Afro-Caribbean populations. American Journal of Human Genetics 67(4 Suppl 2): 223

Leblanc, B.W.; Albina, J.E.; Reichner, J.S. 2003: Beta-glucan increases neutrophil chemotaxis in vivo by a p38 MAPK dependent mechanism. Journal of Leukocyte Biology Suppl: 41

Cahill, A.P.J.; Fenske, D.J.; Freeland, M.; Hartwig, G.W. 2003: Beta-glucan process, additive and food product. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Morgan, Keith Raymond 2002: Beta-glucan products and extraction processes from cereals. Official Gazette of the United States Patent and Trademark Office Patents 1260(5)

Guo, Y.ming; Ali, R.A.; Qureshi, M.A. 2002: Beta-glucan stimulates +AFw-italicizein vitronitrite production in broiler chicken macrophages. Poultry Science 81(Suppl 1): 121

Selitrennikoff, C.P.; Enderlin, C.S. 1999: Beta-glucan synthase genes and inducible inhibition of fungal growth using the antisense constructs derived therefrom. Official Gazette of the United States Patent and Trademark Office Patents 1223(3)

Dongowski, G.; Drzikova, B.; Gebhardt, E.; Habel, A. 2003: Beta-glucan- and resistant starch-rich extrudates on the basis of whole-grain oat meal affect bile acid binding and fermentation in vitro. FASEB Journal 17(4-5): Abstract 190

Hillen, W.; Mauer, K.H.inz 2003: Beta-glucanase from a bacillus. Official Gazette of the United States Patent and Trademark Office Patents 1269(1)

Genta, F.A.; Terra, W.R.; Ferreira, C. 2000: Beta-glucanases from Periplaneta americana midgut. Biochemical Society Transactions 28(5): A310

Sakurai, N. 2000: Beta-glucohydrolase and beta-glucanohydrolase acting on 1,3;1,4-beta-glucan of cereal plants. Ohnishi, Masatake Author Glycoenzymes 115-121

Lebbink, J.H.; Kaper, T.; Kengen, S.W.; van der Oost, J.; de Vos, W.M. 2001: Beta-Glucosidase CelB from Pyrococcus furiosus: production by Escherichia coli, purification, and in vitro evolution. Methods in Enzymology 330: 364-379

Li, X.L.; Ljungdahl, L.G.; Chen, H.; Ximenes, E.A. 2001: Beta-glucosidase coding sequences and protein from orpinomyces PC-2. Official Gazette of the United States Patent and Trademark Office Patents 1243(1)

Gunata, Y.suf Ziy; Vallier, Marie Jose; Baumes, Raymond; Bayonove, Claude 2000: Beta-glucosidase from filamentous fungi, and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1236(2)

Wittig, J.; Smolenski, A.; Thalheimer, P.; Veit, M. 2000: Beta-glucuronidase activity of human endothelial tissues in in-vitro model using primary monolayer cultures of human umbilical vein endothelial cells. Phytomedicine 7(Suppl 2): 113

Moracci, M.; Ciaramella, M.; Rossi, M. 2001: Beta-glycosidase from Sulfolobus solfataricus. Methods in Enzymology 330: 201-215

Easom, R.A. 2000: Beta-granule transport and exocytosis. Seminars in Cell and Developmental Biology 11(4): 253-266

Zdanowski, K.; Dadlez, M. 2000: Beta-hairpin is a folding initiation site in BPTI. Biochemical Society Transactions 28(5): A414

Hamrick, H.J.; Mangum, M.E. 1999: Beta-hemolytic Streptococcus milleri group misidentified as Streptococcus pyogenes on throat culture. Pediatric Infectious Disease Journal 18(1): 75-76

Hameed, A.; Albores Saavedra, J. 2000: Beta-human chorionic gonadotropin positive squamous cell differentiation in endometrioid adenocarcinoma. Laboratory Investigation 80(3): 125A

Gallagher, P.M.; Carrithers, J.A.; Godard, M.P.; Schulze, K.E.; Trappe, S.W. 1999: Beta-hydroxy-beta-methylbutyrate supplementation during resistance training. Medicine and Science in Sports and Exercise 31(5 Suppl): S402

Shimamoto, K.; Yasuda, Y.; Sakaitani, M.; Lebrun, B. 2000: Beta-hydroxyaspartic acid derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Paty, D.W.; Boiko, A.N. 2000: Beta-interferons delay the switch from relapsing-remitting to secondary progressive multiple sclerosis. Neurology 54(7 Supp 3): A337

Ferri, S.R.; Toguri, T. 2001: Beta-ketoacyl-ACP synthetase II enzymes and genes coding for same. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Anderson, D.; Frater, G. 2001: Beta-ketoester compounds. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Garcia, D.L.mas, J.; Granizo, J.J.; Aguilar, L. 1999: Beta-lactam and macrolide resistance seasonality patterns of Streptococcus pneumoniae in Spain. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 90

Yamaguchi, H. 2002: Beta-lactam antibiotic-containing tablet and production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1260(4)

Nakashio, S.; Teruyama, S.; IIno, S. 1999: Beta-lactam antibiotic-induced release of immunostimulatory peptidoglycan and lipoteichoic acid from staphylococci. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 169-170

Schmidt, F.R. 2002: Beta-lactam antibiotics Aspects of manufacture and therapy. Esser, K , Bennett, J W The Mycota: A comprehensive treatise on fungi as experimental systems for basic and applied research Industrial applications 71-91

Burnett, D.A. 2004: Beta-lactam cholesterol absorption inhibitors. Current Medicinal Chemistry 11(14): 1873-1887

Sunagawa, M.; Yamaga, H.; Nouda, H.; Shinagawa, H. 2001: Beta-lactam compounds and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1248(4)

Sunagawa, M.; Yamaga, H.; Sumita, Y.; Shinagawa, H. 2003: Beta-lactam compounds and process for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1272(5)

Bondinell, W.E.; Winkler, J.D.vid 2001: Beta-lactam inhibitors of CoA-IT. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Gerlach, B.; Ludescher, J.; Totschnig, K. 2003: Beta-lactam production. Official Gazette of the United States Patent and Trademark Office Patents 1269(4)

Krediet, T.G.; Voet, W.; Gerards, L.J.; Fleer, A. 2002: Beta-lactam resistance in relation to mecA gene carriage and expression of PBP-2a of coagulase-negative staphylococcal blood isolates in a neonatal intensive care unit. Pediatric Research 51(4 Part 2): 302A

Gonzalez Rizo, A.; Salazar Rodriguez, D.; Rojas Hernandez, N.; Hernandez Carpio, Y. 2003: Beta-lactam resistance mediated by plasmids in Pseudomonas aeruginosa clinical isolates. Acta Farmaceutica Bonaerense 22(3): 231-238

Kettner, M.; Michalkova Papajova, D.; Cernicka, J.; A. Krajcikova, J.; Rovna, D.; Macickova, T. 2001: Beta-lactam, aminoglycoside and fluoroquinolone resistance in clinical isolates of the genus Acinetobacter obtained from the burn infections. International Journal of Antimicrobial Agents 17(Suppl 1): S134

Fosse, T.; Giraud Morin, C.; Madinier, I. 2003: Beta-lactam-resistance phenotypes in the genus Aeromonas. Pathologie Biologie 51(5): 290-296

Besterman, J.M.; Rahil, J.; Pratt, R. 2003: Beta-lactamase and DD-peptidase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1273(3)

Avison, M.B.; Walsh, T.R.; Bennett, P.M. 1999: Beta-lactamase expression in Plesiomonas shigelloides. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 153

Buynak, J.D.; Rao, A.S.; Adam, G.C.; Nidamarthy, S.D.; Doppalapudi, V.R. 2002: Beta-lactamase inhibiting compounds. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Karlowsky, J.A.; Verma, G.; Zhanel, G.G.; Hoban, D.J. 1999: Beta-lactamase-positive cefaclor-resistant Haemophilus influenzae harbour ROB-1 beta-lactamase more commonly than TEM-1. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 152

Bush, K. 1999: Beta-Lactamases of increasing clinical importance. Current Pharmaceutical Design 5(11): 839-845

Gandolfo, M.; De Barrio, M.; Tomero, P.; Fuentes, V.; De Frutos, C.; Rodriguez, B.; Herrero, T. 2001: Beta-lactams allergy Unusual way to confirm the sensitization during the diagnostic procedure. Allergy 56(Suppl 68): 229

Thottathil, J.K.; Trifunovich, I.D.; Kucera, D.J.; Li, W.S.n 2001: Beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes. Official Gazette of the United States Patent and Trademark Office Patents 1251(5)

Palupi, N.S.; Franck, P.; Belleville Nabet, F.; Nabet, P.; Dousset, B.; Linden, G.; Guimont, C. 1999: Beta-lactoglobulin modifications characterized by mass spectrophotometry lead to different activity on hybridoma cell culture. Proceedings of the Nutrition Society 58(3): 95A

D'alfonso, L.; Collini, M.; Baldini, G. 2003: Beta-lactoglobulin stability and hydration in the presence of trehalose by time resolved fluorescence. European Biophysics Journal 32(3): 243

Hale, J.E.; Heiman, M.L.; Schoner, B.E.; Heath, W.F., J. 2001: Beta-lipotropin methods. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)

Chhabra, S.; Parker, K.N.; Lam, D.; Callen, W.; Snead, M.A.; Mathur, E.J.; Short, J.M.; Kelly, R.M. 2001: Beta-mannanases from Thermotoga species. Methods in Enzymology 330: 224-238

Parker, K.N.; Chhabra, S.; Lam, D.; Snead, M.A.; Mathur, E.J.; Kelly, R.M. 2001: Beta-Mannosidase from Thermotoga species. Methods in Enzymology 330: 238-246

Anwar, M.A.; Schwab, M.; Poston, L.; Nathanielsz, P.W. 1999: Beta-methasone produces hypovolemia in fetal sheep Possible rheological implications of changed hematological profile. Biorheology 36(1-2): 159-160

Laugraud, S.; Laugtaud, B.P.; Laugraud, B.R.; Laugraud, B.P.; Laugraud, B.B.; Sollossi, B.M.; Reinier, N. 1999: Beta-methoxy acrylic acid derivatives, method for preparing same, and use of said derivatives as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)

Vincze, S.; Szedlay, G. 2002: Beta-methoxyacrylates in fungi. Acta Microbiologica et Immunologica Hungarica 49(2-3): 389

Tourwe, D.; Toth, G.; Carlens, G.; Tomboly, C.; Peter, A.; Schiller, P.W. 2003: Beta-methyl substitution of the Cha residue in Dmt-Tic-Cha-Phe peptides provides highly potent delta antagonists. Biopolymers 71(3): 367

Giraud, M.; Potier, P.; Andriamialisoa, Z.; Valla, A. 1999: Beta-methylene aldehydes and preparation of compounds of interest by means of the beta-methyl aldehydes. Official Gazette of the United States Patent and Trademark Office Patents 1224(3)

Vandenboom, R.; Fomicheva, E.; Albayya, F.P.; Metzger, J.M. 2004: Beta-myosin heavy chain gene transfer attenuates shortening of adult rat cardiac myocytes. Biophysical Journal 86(1): 184a

Steyn, S.J.; Mienie, L.J.; Van Der Schyf, C.J. 2000: Beta-oxidation of -3Hpalmitate by human leukocytes A simple in situ assay to assess mitochondrial toxicity in the presence of toxins. Toxicology Methods 10(2): 99-109

D.N.s, K.; Meyhi, E.; Asselberghs, S.; Mannaerts, G.; Van Veldhoven, P. 2001: Beta-oxidation of docosahexaenoic acid and tetracosahexaenoic acid in isolated rat hepatocytes and human fibroblasts. Biochemical Society Transactions 29(1): A23

Gellman, S.H. 1999: Beta-peptide foldamers. Abstracts of Papers American Chemical Society 217(1-2): ORGN 319

Schenk, D.B.; Seubert, P.; Lieberburg, I.; Wallace, J. 2000: Beta-peptide immunization: a possible new treatment for Alzheimer disease. Archives of Neurology 57(7): 934-936

Gademann, K.; Hintermann, T.; Schreiber, J.V. 1999: Beta-peptides: twisting and turning. Current Medicinal Chemistry 6(10): 905-925

Schoop, A.; Mueller, G.; Brueggemeier, U.; Schmidt, D.; Stelte Ludwig, B.; Keldenich, J. 2001: Beta-phenylalanine derivatives as integrin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1250(3)

Gellman, S.H.; Appella, D.H.; Christianson, L.A.; Klein, D.A.; Krauthauser, S.; Chung, Y.J.; Wang, X. 2000: Beta-polypeptide foldamers of well-defined secondary structure. Official Gazette of the United States Patent and Trademark Office Patents 1234(2)

Monobe, M.; Arimoto Kobayashi, S.; Ando, K. 2003: Beta-pseudouridine reduces radiation-induced chromosome aberrations in human lymphocytes. Journal of Radiation Research 44(4): 426

Gijzel, A.L.; Sabate, M.; Kay, I.P.; Wardeh, A.J.; Van Der Giessen, W.J.; Coen, V.L.M.A.; Levendag, P.C.; Serruys, P.W. 1999: Beta-radiation for the treatment of recurrent in-stent restenosis. European Heart Journal 20(ABSTR Suppl ): 25

Munzel, T.; Mollnau, H.; Oelze, M.; Smolenski, A.; Walter, U. 2000: Beta-receptor blockade with nebivolol improves endothelial dysfunction in angiotensin II hypertension by increasing NOS III expression and by preventing NOS III uncoupling. Circulation 102(18): 2; 80

Kyser, C.K.; Carroll, J.F.; Martin, M.W. 2000: Beta-receptor density increases in obese rabbits. FASEB Journal 14(4): A157

Rosebraugh, C.J.; Barbey, J.T.; Funck Brentano, C.; Yasuda, S.U. 1999: Beta-receptor occupancy after chronic bisoprolol dosing. Clinical Pharmacology and Therapeutics 65(2): 150

Melacini, P.; Fanin, M.; Boito, C.; Pegoraro, E.; Angelini, C.; Iliceto, S. 2002: Beta-sarcoglycan gene mutations cause plasma membrane dysruption in striated and smooth muscle, leading to severe dilated cardiomyopathy. European Heart Journal 23(Abstract Suppl): 126

Chrysler, S.M.S.; Sinha, S.; Keim, P.S.; Anderson, J.P.; Tan, H.; Mcconlogue, L.C.air 2001: Beta-secretase antibody. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Anderson, J.P.; Basi, G.; Doan, M.T.; Frigon, N.; John, V.; Power, M.; Sinha, S.; Tatsuno, G.; Tung, J.; Wang, S.; Mcconlogue, L. 2003: Beta-secretase enzyme compositions and methods. Official Gazette of the United States Patent and Trademark Office Patents 1274(5)

Regan, L. 2002: Beta-sheet and fiber formation in simple model systems. Abstracts of Papers American Chemical Society 223(1-2): PHYS 149

Bieler, S.; Soto, C. 2004: Beta-sheet breakers for Alzheimer's disease therapy. Current Drug Targets 5(6): 553-558

Qabar, M.N.; Mcmillan, M.K.; Kahn, M.S.; Tulinsky, J.E.; Ogbu, C.O.; Mathew, J. 2002: Beta-sheet mimetics and methods relating to the use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Kahn, M.; Ogbu, C.O.; Eguchi, M.; Kim, H.O.; Boatman, P.D.uglas 2001: Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)

Kahn, M. 2000: Beta-sheet mimetics and use thereof as protease inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1231(1)

Kelly, J.W. 2000: Beta-sheet nucleating peptidomimetics. Official Gazette of the United States Patent and Trademark Office Patents 1232(1)

Mathews, J.A.; Delong, M.A.; Cohen, S.L.; Wireko, F.C.; Ritter, A.L.; Gudmundsdottir, A.D. 2003: Beta-silyl arenes Novel substrates for the arene-olefin photocyclization reaction. Abstracts of Papers American Chemical Society 225(1-2): ORGN 661

Awad, A.B.; Roy, R.; Fink, C.S. 2002: Beta-sitosterol , a plant sterol, activates key caspases in human breast cancer. International Journal of Molecular Medicine 10(Suppl 1): S22

Roberts, B.A.; Scavone, T.A.; Riedell, S.P. 2000: Beta-stable low-saturate, low trans, all purpose shortening. Official Gazette of the United States Patent and Trademark Office Patents 1232(1)

Pignier, C.; Egger, M.; Niggli, E. 2002: Beta-stimulation shortens recovery of sarcoplasmic Ca2+ release. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S293

Warpehoski, M.A.; Harper, D.E. 2001: Beta-sulfonyl hydroxamic acids. Official Gazette of the United States Patent and Trademark Office Patents 1246(4)

Limprasert, P.; Taylor, J.P.; Leverenz, J.; Tsuang, D.; Bonner, L.; Tanaka, F.; Bird, T.D.; Sopher, B.L.; La Spada, A.R. 2001: Beta-synuclein gene alteration in dementia with Lewy bodies. American Journal of Human Genetics 69(4 Suppl): 196

Limprasert, P.; Murray, I.V.J.; Tsuang, D.W.; Leverenz, J.B.; Lee, V.M.Y.; Trojanowski, J.Q.; La Spada, A.R. 2002: Beta-synuclein transgenic mice show significant reductions in alpha-synuclein protein expression levels. American Journal of Human Genetics 71(4 Suppl): 165

Varesi, L.; Vona, G.; Memmi, M.; Marongiu, F.; Ristaldi, M.S. 2000: Beta-thalassemia mutations in Corsica. Hemoglobin 24(3): 239-244

Novembre, E.; Cianferoni, A.; Capra, L.; Rossi, M.E.; Bernardini, R.; Marcucci, F.; Pucci, N.; Vierucci, A. 2002: Beta-thalassemic patients are not at risk for latex allergy. Allergy 57(9): 865-866

Bateson, J.H.; Best, D.J.; Clarke, B.P.; Gilpin, M.L.; Witty, D. 2000: Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1241(1)

Ozeki, H.; Matsunaga, N.; Nozaki, M.; Tomida, K.; Sakurai, E.; Ogura, Y.; Hirabayashi, Y.; Shimada, S. 2001: Beta-thujaplicin-induced experimental models for human congenital anomalies of the eye in mouse fetuses. IOVS Investigative Ophthalmology and Visual Science 42(4): S381

Donadio, C.; Lucchesi, A.; Ardini, M.; Giordani, R. 2002: Beta-trace protein A new marker for glomerular filtration rate impairment. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 113

Brettschneider, J.; Riepe, M.W.; Ludolph, A.C.; Tumani, H. 2003: Beta-trace protein in cerebrospinal fluid A diagnostic marker for patients with normal pressure hydrocephalus. Neurology 60(5 Suppl 1): A206

Dorta Contreras, A.J.; Reiber, H.; Aguero Valdes, E.; Escobar Perez, X.; Ferra Valdes, M. 1999: Beta-trace protein in pediatric patients with Cuban epidemic neuropathy and Cuban children without neuropathies. Alzheimer's Disease Review 4(CITED DEC 6, ): 10-12

Poege, U.; Gerhardt, T.M.; Klehr, H.U.; Stoffel Wagner, B.; Sauerbruch, T.; Woitas, R.P. 2003: Beta-trace protein in the early post transplantation period. Journal of the American Society of Nephrology 14(Abstracts Issue): 439A

Milner, B.J.; Vickers, M.A.; Schofield, A.C.; Culligan, D.J.; Tighe, J.E.; Haites, N.E.; King, D.J. 2000: Beta-tubulin gene mutations and response to vinca alkaloids in acute lymphoblastic leukaemia. Journal of Medical Genetics 37(Suppl 1): S42

He, L.; Yang, C.P.ng H.; Horwitz, S.B.nd 2001: Beta-tubulin mutations in epothilone-resistant cells map to domains involved in the regulation of microtubule stability. Proceedings of the American Association for Cancer Research Annual Meeting 42: 921-922

Campbell, J.L.; Budd, M.E. 2001: Beta-type DNA polymerases. Official Gazette of the United States Patent and Trademark Office Patents 1248(1)

D.G., L.H.; Van Peij, N.N. Maria, E. Van Den Broeck, H.C.; Visser, J. 2001: Beta-xylosidase, nucleotide sequence encoding it, and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)

Randall, J.J.; Kikuta Oshima, L.C.; Kemp, J.D.; Ghoshroy, S. 2001: Beta/delta Zein fusion proteins in transgenic tobacco. Plant Biology (Rockville) : 150

Pesce, L.; Guerrero, C.; Sznajder, J.I. 1999: Beta1 Adrenergic stimulation increases MAPK/ERK activity in alveolar epithelial cells via protein kinase A. FASEB Journal 13(4 Part 1): A470

Mercado, M.L.T.; Meiners, S.; Geller, H.M. 1999: Beta1 Integrin is essential for neuronal guidance. Society for Neuroscience Abstracts 25(1-2): 1280

Rowin, M.E.; Xue, V. 2001: Beta1 Integrin stimulation causes NF-kappaB activation in granulocytic HL-60 cells. Pediatric Research 49(4 Part 2): 43A

Rowin, M.E.; Wolfe, V.; Solomkin, J.S. 2002: Beta1 Integrin stimulation increases IL-8 production in granulocytic HL-60 cells. Pediatric Research 51(4 Part 2): 255A

Bellingan, G.J.; Xu, P.; Cooksley, H.; Mutsaers, S.E.; Laurent, G.J. 2002: Beta1 Not beta2 integrins regulate macrophage clearance from the inflamed site. Clinical Science (London) 103(1): 73P

Sosunov, E.A.; Gainullin, R.Z.; Sydney Moise, N.; Danilo, P., J.; Rosen, M.R. 1999: Beta1 and beta2 adrenergic receptor subtype effects in German Shepherds with inherited lethal ventricular arrhythmias. Circulation 100(18): 1; 270

Lavandero, S.; Moraga, F.; Mellado, R.; Chiong, M.; Diaz Araya, G.; Castro, P.; Greig, D.; Perez, O.; Moreno, M. 2003: Beta1 and beta2-Adrenergic receptor gene polymorphisms are not associated with heart failure. FASEB Journal 17(4-5): Abstract 401

Stallmach, A.; Giese, T.; Humphries, M.J.; Zeitz, M.; Meuer, S. 1999: Beta1 integrin co-stimulation restores in intestinal lymphocytes CD3-mediated responsiveness. Immunology Letters 69(1): 96

Bellis, S.L. 2001: Beta1 integrin glycosylation and function are coordinately regulated by protein kinase C and ras. Proceedings of the American Association for Cancer Research Annual Meeting 42: 148

Mainiero, F.; Soriani, A.; Jacobelli, J.; Strippoli, R.; Gismondi, A.; Morrone, S.; Santoni, A. 1999: Beta1 integrin ligation induce cytokine and chemokine expression in human NK cells. FASEB Journal 13(5 Part 2): A962

Rowin, M.E.; Wolfe, V.; Robinson, C.; Solomkin, J.S. 2003: Beta1 integrin-dependent activation of NF-kappaB utilizes the tyrosine kinase Syk. Pediatric Research 53(4 Part 2): 349A-350A

Rowin, M.E.; Wolfe, V.; Solomkin, J.S. 2003: Beta1 integrins activate the NF-kappaB pathway through the glycoprotein IIb/IIIa fibronectin recognition site. Pediatric Research 53(4 Part 2): 43A-44A

Masumoto, A.; Arao, S.; Otsuki, M. 1999: Beta1 integrins play an essential role in adhesion and invasion of hepatocellular carcinoma cells. Gastroenterology 116(4 Part 2): A1244

Johnson, D.; Montpetit, M.L.; Stocker, P.J.; Bennett, E.S. 2004: Beta1 modulation of Nav channel gating is a sialic acid-dependent process. Biophysical Journal 86(1): 422a

Sugita, Y.rika; Fujiwara, Yoshiyuki; Miyamoto, Atsushi; Kuo, Christine, T.; Hoon, Dave, S.B.; Monden, Morito 2000: Beta1, 4N-acetylgalactosaminyltransferase A potential molecular marker for monitoring patients with various types of cancers. Proceedings of the American Association for Cancer Research Annual Meeting 41: 527

Sartiani, L.; Cerbai, E.; Depaoli, P.; Bizzarri, F.; Diciolla, F.; Davoli, G.; Sani, G.; Nisoli, E.; Carruba, M.; Mugelli, A. 1999: Beta1, beta2 and beta3 adrenoceptor subtypes differently modulate the pacemaker current in human ventricular myocytes. Circulation 100(18): 1; 489

Sakamoto, Y.; Watanabe, H.; Tano, Y. 1999: Beta1,3N-acetylglucosaminyltransferase involving keratan sulfate biosynthesis in developing embryonic chicken corneas. IOVS Investigative Ophthalmology and Visual Science 40(4): S624

Humma, L.M.; Nguyen, N.B.; Wallace, M.R.; Farmerie, W.G.; Johnson, J.A. 2000: Beta1- and beta2-adrenergic receptor polymorphisms and diurnal blood pressure variation. Pharmacotherapy 20(10): 1262-1263

Humma, L.M.; Puckett, B.J.; Lejeune, B.L.; Mcnamara, D.M.; Pepine, C.J.; Johnson, J.A. 2001: Beta1-Adrenergic receptor polymorphisms and obesity. Clinical Pharmacology and Therapeutics 69(2): P63

Zineh, I.; Puckett, B.J.; Mcgorray, S.P.; Pauly, D.F.; Johnson, J.A. 2002: Beta1-Adrenergic receptor polymorphisms predict antihypertensive response to beta-blockers. Circulation 106(19): II574

Keys, J.R.; Eckhart, A.D. 2003: Beta1-Adrenergic receptors mediate hypertension in mice with vascular-specific GRK5 overexpression. Circulation 108(17): IV268

Bundkirchen, A.; Brixius, K.; Boelck, B.; Nguyen, Q.; Schwinger, R.H.G. 2003: Beta1-Adrenoceptor selectivity of nebivolol and bisoprolol A comparison of CGP 12177 and iodocyanopindolol binding studies. European Journal of Pharmacology 460(1): 19-26, 26 January

Brahmadevara, N.; Hillier, C.; Shaw, A.M.; Macdonald, A. 2003: Beta1-Adrenoceptors mediate endothelium-independent relaxation in rat femoral resistance arteries. British Journal of Pharmacology 138(Proceedings Suppl): 154P

Praetorius, H.A.; Frokiaer, J.; Praetorius, J.; Nielsen, S.; Spring, K.R. 2002: Beta1-Integrin is expressed on the primary cilia of MDCK cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 739A

Wittig, B.M.; Humphries, M.J.; Meuer, S.; Zeitz, M.; Stallmach, A. 2000: Beta1-Integrins mediate contra-apoptotic signals in CD4+ lamina propria lymphocytes. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A354

Shain, K.H.; Loughran, T.; Dalton, W.S. 2000: Beta1-Mediated adhesion to fibronectin protects cells from CD95-mediated apoptosis. Experimental Hematology 28(7 Suppl 1): 76

Wang, D.; Wilcox, C.S. 2003: Beta1-Receptors protect the renal afferent arteriole from angiotensin II-induced oxidative stress. Journal of the American Society of Nephrology 14(Abstracts Issue): 137A-138A

Zhu, W.; Hagemann, D.; Chakir, K.; Xiao, R.P.ng 2001: Beta1-adrenergic receptor induced cardiac apoptosis is mediated by Ca2+/calmodulin-dependent kinase II rather than PKA. Circulation 104(17): 2; 143

Beitelshees, A.L.; Cavallari, L.H.; Gaston, K.L.; Okorochukwu, T.U.; Johnson, J.A. 2004: Beta1-adrenergic receptor polymorphisms and hypertension. Clinical Pharmacology and Therapeutics 75(2): P61

Yang, Y.F.; Kirigiti, P.; Li, B.; Moudgil, T.; Machida, C.A. 1999: Beta1-adrenergic receptor promoter recognizes potential AP-2 like transcription factor and other central nervous system transactivators. Society for Neuroscience Abstracts 25(1-2): 720

Xiao, L.; Shen, M.; Colucci, W.S. 2002: Beta1-adrenergic receptor stimulation inhibits alpha1-AR-stimulated hypertrophic signaling in adult rat ventricular myocytes via activation of cyclic AMP-protein kinase A cascade. Circulation 106(19): II48

Konkar, A.A.; Zhai, Y.; Granneman, J.G. 2000: beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Molecular Pharmacology 57(2): 252-258

Shi, X.; Formes, K.J.; Wray, D.W.; Yurvati, A.H.; Weiss, M.S.; Raven, P.B. 2001: Beta1-adrenoceptor antagonist inhibits plasma renin activity and raterial blood pressure variability during central hypovolemia. FASEB Journal 15(5): A1147

Sampaio, K.N.; Biancardi, V.C.; Vasquez, E.C.; Mauad, H. 2000: Beta1-adrenoceptor blockade affects the inhibition of the baroreflex bradycardia elicited by the dorsolateral periaqueductal grey matter in the rat. Journal of Physiology (Cambridge) (523P): 268P-269P

Igel, S.; Schaeffeler, E.; Schwab, M.; Jaegle, C.; Drescher, S.; Moerike, K.; Gleiter, C.H.; Eichelbaum, M. 2003: Beta1-adrenoceptor polymorphisms in patients with atrial fibrillation after cardiac surgery. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R120

Leineweber, K.; Bogedain, P.; Rohe, P.; Schulte Herbruggen, J.; Jacob, H.G.; Brodde, O.E. 2004: Beta1-adrenoceptor-haplotype dependent alterations in right atrial beta-adrenoceptor density of patiens with coronary artery disease treated with metoprolol. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R24

Stallmach, A.H.; Wittig, B.M.; Humphries, M.J.; Meuer, S.; Zeitz, M. 2000: Beta1-integrins deliver a contra-apoptotic signal on CD4+ lamina propria lymphocytes in inflammatory bowel disease. FASEB Journal 14(6): A976

Lipsius, S.L.; Samarel, A.M. 2004: Beta(1)-integrins modulate beta-adrenergic receptor signaling. Journal of Molecular and Cellular Cardiology 36(6): 795-798

Boivin, V.; Triebel, S.; Hein, L.; Angermann, C.E.; Lohse, M.J.; Jahns, R. 2002: Beta1-receptor directed immune-cardiomyopathy in the rat is characterized by left chamber dilatation, unchanged myocardial collagen content, and by down-regulation of cardiac beta1-adrenoceptors. Circulation 106(19): 2; 426

Deschenes, D.; O'leary, M.E.; Chahine, M. 2000: Beta1-subunit causes a localized conformational change in the D4S6 segment of hH1 sodium channels. Biophysical Journal 78(1 Part 2): 87A

Petkov, G.V.; Heppner, T.J.; Bonev, A.D.; Brenner, R.; Aldrich, R.W.; Nelson, M.T. 2001: Beta1-subunit of Ca2+-activated K+ channels regulates contractile activity of urinary bladder smooth muscle. FASEB Journal 15(5): A843

Lewis, C.J.; Gong, H.; Brown, M.J.; Harding, S.E. 2003: Beta1/beta2-adrenoceptor heterodimerization enhances the beta4-like cardiostimulant effects of CGP 12177A in adult rat cardiomyocytes. Circulation 108(17): IV1

Laufik, M.; Ross, R.S.; Villareal, F.J.; Omens, J.H.; Covell, J.W. 2002: Beta1D integrin expression in rat myocytes within scar tissue collected 12 hours to 2 weeks following myocardial infarction. Journal of Investigative Medicine 50(1): 40A

Wang, G.; Asico, L.D.; Hopfer, U.; Jose, P.A.; Xu, J. 2004: Beta2 Adrenergic Receptor, NHERF, and GRK6 Expressions in Spontaneously Hypertensive Rats. FASEB Journal 18(4-5): Abstract 436

Ramos, Fernando; Da Silveira, Maria Irene Noronha 2001: Beta2 Adrenergic agonist and animal producti II Structure-activity relationship and pharmacokinetic. Revista Portuguesa de Ciencias Veterinarias 96(540): 167-175

Iaccarino, Guido; Lanni, Francesca; Cipolletta, Ersilia; Timarco, Valentina; Izzo, Raffaele; Iovino, Gian Luigi; De Luca, Nicola; Rossi, Francesco; Trimarco, Bruno 2002: Beta2 Adrenergic receptor polymorphisms, blood pressure levels, cardiac size and vascular damage in hypertension. Circulation 106(19): II107

Mahlab, D.S.; Postava, L.A.; Holubkov, R.; Shilkofski, J.; Macgowan, G.A.; Mathier, M.A.; Murali, S.; Janosko, K.; Feldman, A.M.; London, B.; Mcnamara, D.M. 2002: Beta2 Adrenergic receptor variant Ile164 Effect on heart failure survival and impact of beta blockade. Journal of the American College of Cardiology 39(5 Suppl A): 135A

Prieto, G.A.; Cabral, A.R.; Cabiedes, J. 2002: Beta2 Glycoprotein I polymorphism Its role in antiphospholipid syndrome. Revista Espanola de Reumatologia 29(8): 396-404

Masauzi, N.; Tanaka, J.; Saitoh, S.; Kawamura, T.; Tsutsumi, Y.; Obara, S.; Matsushima, T.; Kasai, M.; Asaka, M.; Imamura, M.; Kobayashi, M. 2002: Beta2 Integrin Expression on Peripheral Blood CD34 Positive Cells; a Possibility of Estimation of a Total Amount of Harvesting CD34+ Cells before Granulocyte Colony-Stimulating Factor Administration. Blood 100(11): Abstract No. 5219

Franco Junior, J.G.; Baruffi, R.L.R.; Garbellini, E.; Felipe, V.; Petersen, C.; Mauri, A.L. 2001: Beta2 Receptor agonists during the peri-implantation period could improve implantation and pregnancy rates. Human Reproduction 16(Abstract Book 1): 77

Dishy, V.; Cahana, R.L.; Sofowora, G.; Xie, H.; Smiley, R.M.; Kim, R.B.; Byrne, D.W.; Wood, A.J.; Stein, C.M. 2003: Beta2 adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Clinical Pharmacology and Therapeutics 73(2): P1

Dibas, M.I.; Dillon, G.H. 1999: Beta2 has differential effects on the interaction of picrotoxin-related drugs with GABAA receptors. Society for Neuroscience Abstracts 25(1-2): 1481

Perez, Mary Shirley 1999: Beta2 integrin cell adhesion molecule inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1223(3)

Nielsen, O.H.; Vainer, B. 2000: Beta2 integrins inhibit ICAM-1 induced neutrophil locomotion in ulcerative colitis. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A349

Yoshikawa, H.; Kawashirna, S.; Shikano, M.; Hasegawa, H.; Toba, T.; Tomita, M.; Hasegawa, M.; Murakami, K.; Katsumata, H.; Kushimoto, H. 1999: Beta2 microglobulin amyloidosis, dialysis membrane type and amyloid related protein levels in the serum. Nephrology Dialysis Transplantation 14(9): A231

Ribaudo, R.K.; Shields, M. 2004: Beta2 microglobulin fusion proteins and high affinity variants. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Yang, D.; Zhang, Y.-H.; Zhu, N.-Y. 2002: Beta(2,2)-Aminoxy acids: a new building block for turns and helices. Journal of the American Chemical Society 124(34): 9966-9967

Jo, S.H.; Hagemann, D.; Xiao, R.P. 2001: Beta2-Adrenergic Gi signaling negates the concurrent Gs-mediated cardiac phospholamban phosphorylation by activation of phosphoinositide 3 kinase. Circulation 104(17): 2; 144

He, J.Q.; Haworth, R.A.; Kamp, T.J. 2002: Beta2-Adrenergic mediated phosphatase activation markedly blunts beta-adrenergic stimulation of ICa in tachycardia-induced heart failure. Circulation 106(19): II256

Fukui, H.; Kawakami, N.; Miyoshi, K.; Kodama, M.; Horio, S. 2004: Beta2-Adrenergic receptor activation-induced histamine H1 receptor down-regulation. Journal of Pharmacological Sciences 94(Suppl 1): 250P

Feng, Y.; Nguyen, A.N.; Lam, A.; Kapoun, A.M.; Henson, M.; Chakravarty, S.; Schreiner, G.F.; Higgins, L.S. 2003: Beta2-Adrenergic receptor expression and function in cardiomyocytes are down-regulated by TGF-beta type I receptor kinase activity. Circulation 108(17): IV77

Forleo, C.; Guida, P.; Sorrentino, S.; Romito, R.; Resta, N.; Guanti, G.; Rizzon, P.; Pitzalis, M.V. 2002: Beta2-Adrenergic receptor gene polymorphisms are genetic susceptibility factors to idiopathic dilated cardiomyopathy. European Heart Journal 23(Abstract Suppl): 393

Garovic, V.D.; Joyner, M.J.; Dietz, N.M.; Boerwinkle, E.; Turner, S.T. 2002: Beta2-Adrenergic receptor haplotypes and forearm vasodilatory responses to isoproteronol in humans. American Journal of Hypertension 15(4 Part 2): 155A-156A

Jones, S.M.; Cornett, L.E.; Foreman, S.K.; Kurten, R.C. 2000: Beta2-Adrenergic receptor membrane trafficking and down-regulation following prolonged agonist exposure. Journal of Investigative Medicine 48(1): 141A

Galasso, G.; Laccarino, G.; Piscione, F.; Barbato, E.; Marrazzo, G.; De Luca, G.; Trimarco, B.; Chiariello, M. 2002: Beta2-Adrenergic receptor polymorphism THR164ILE is an independent predictor of severe coronary artery disease. European Heart Journal 23(Abstract Suppl): 186

Lavandero, S.; Moraga, F.; Mario, C.; Diaz Araya, G.; Vukasovic, J.L.; Pablo, C.; Perez, O.; Moreno, M.; Ocaranza, M.P.; Jalil, J.; Ivonne, P.; Nazal, C.; Corbalan, R. 2002: Beta2-Adrenergic receptor polymorphisms are not associated with heart failure. FASEB Journal 16(4): A587

Ramberg, H.; Eide, T.; A. Krobert, K.; J. Tindall, D.; O. Levy, F.; Austlid Tasken, K. 2004: Beta2-Adrenergic receptor regulation in prostate cancer upon androgen deprivation. European Urology Suppls 3(2): 148

Rami, A.; Oelschlaeger, H.A.; Winckler, J. 1999: Beta2-Adrenergic receptor responsiveness of calpastatin and attenuation of apoptosis after ischemia. Society for Neuroscience Abstracts 25(1-2): 300

Burniston, J.G.; Tan, L.B.; Goldspink, D.F. 2002: Beta2-Adrenergic receptor stimulation by clenbuterol in vivo induces apoptosis in the rat heart. Journal of Physiology (Cambridge) 543P: 38P-39P

Turner, N.A.; Porter, K.E.; Smith, W.H.T.; White, H.L.; Balmforth, A.J. 2002: Beta2-Adrenergic receptor-induced proliferation of human cardiac fibroblasts. Biochemical Society Transactions 30(1): A42

Steinberg, S.F.; Hu, D.; Pak, E.S.; Rybin, V.O.; Alcott, S.G. 1999: Beta2-Adrenergic receptors do not signal through pertussis toxin-sensitive G proteins in neonatal rat ventricular myocytes. Circulation 100(18): 1; 488

Carlin, R.W.; Diesel, A.B.; Wangemann, P.; Schultz, B.D. 2003: Beta2-Adrenergic receptors modulate cAMP concentration and ion transport across vas deferens epithelia. FASEB Journal 17(4-5): Abstract 329

Nakamura, A.; Imaizumi, A.; Yanagawa, Y.; Kohsaka, T.; Johns, E.J. 2000: Beta2-Adrenoceptor activation protects against Shiga toxin-induced apoptosis via p38 mitogen-activated protein kinase. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 606A

Nakamura, A.; Imaizumi, A.; Yanagawa, Y.; Kohsaka, T.; Johns, E. 2002: Beta2-Adrenoceptor activation suppresses shiga toxin2-triggered apoptosis in renal tubular epithelial cells. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 207

Zhu, Y.; Culmsee, C.; Roth Eichhorn, S.; Krieglstein, J. 1999: Beta2-Adrenoceptor agonist clenbuterol upregulates TGF-beta1 immunoreactivity in rat brain after global ischemia. Society for Neuroscience Abstracts 25(1-2): 1274

Nakamura, A.; Imaizumi, A.; Niimi, R.; Yanagawa, Y. 2004: Beta2-Adrenoceptor gene delivery affords the kidney protection against endotoxin-induced acute renal failure. Journal of Pharmacological Sciences 94(Suppl 1): 105P

Gardiner, S.M.; March, J.E.; Kemp, P.A.; Bennett, T. 2002: Beta2-Adrenoceptor involvement in the hindquarters vasodilator effects of WIN 55212-2, HU 210 and anandamide in conscious Sprague-Dawley rats. British Journal of Pharmacology 135(Proceedings Suppl): 202P

Wolk, R.; Somers, V.K.; Turner, S.T.; Olson, L.; Johnson, B. 2003: Beta2-Adrenoceptor polymorphism A potential role in modulating pulmonary function in heart failure. Journal of the American College of Cardiology 41(6 Suppl A): 211A-212A

Bruck, H.; Leineweber, K.; Brodde, O.E.ich 2003: Beta2-Adrenoceptor polymorphisms and venodilation. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R117

Altschuld, R.A.; Billman, G.E. 2000: Beta(2)-Adrenoceptors and ventricular fibrillation. Pharmacology and Therapeutics 88(1): 1-14

Jones, S.W.; Timmons, J.A.; Baker, D.J.; Greenhaff, P.L. 2002: Beta2-Adrenoreceptor agonist-induced changes in muscle fibre type are preceded by upregulation of MyoD in rat skeletal muscle. Journal of Physiology (Cambridge) 539P: 28P

Harats, D.; George, J. 2001: Beta2-glycoprotein i and atherosclerosis. Current Opinion in Lipidology 12(5): 543-546

D.S., A.R.; Palerme, J.S.; Levine, J.S.; Rauch, J. 2003: Beta2-Glycoprotein I-specific T cell response in a model of anti-phospholipid induction. FASEB Journal 17(7): C40

Kuczynski, Edward; Radunovic, Nebojsa; Di Renzo, Gian Carlo; Lockwood, Charles 2001: Beta2-Microglobulin levels A potential marker of fetomaternal histocompatibility. American Journal of Obstetrics and Gynecology 184(1): S92

Mishurovskaja, T.; Belousova, T.; Vinnitsky, L.; Dolgova, M.; Velikanov, T. 2000: Beta2-Microglobulin plasma level in remission as a prognostic test of the severity of relapse in ulcerative colitis. Digestive and Liver Disease 32(Suppl 1): A25

Inui, M.; Nakamura, S.; Nomura, J.; Okumura, K.; Tagawa, T. 2002: Beta2-Microglobulin purified from the conditioned medium of malignant melanoma cell induced apoptosis to melanoma cell. Pigment Cell Research 15(Suppl 9): 79-80

Krieter, D.H.; Mueller Groh, F.; Reinhardt, B.; Sauer, N.; Brandt, T.; Lemke, H.D.; Canaud, B.; Quellhorst, E. 2001: Beta2-Microglobulin removal and albumin loss in hemodiafiltration with three high-flux hemodiafilters. Kidney and Blood Pressure Research 24(4-6): 296-297

Terrier, N.; Senecal, L.; Moragues, H.L.; Krieter, D.H.; Bonardet, A.; Cristol, J.P.; Tetta, C.; Canaud, B. 2002: Beta2-Microglobulin removal and albumin loss using post-dilutional on-line haemodiafiltration with Diapes HF800 Effect of glucose administration. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 154-155

Campistol, J.M.; Torregrosa, J.V.; Ponz, E.; Fenollosa, B. 1999: Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes. Contributions to Nephrology 125: 76-85

Peters, M.F.; Houlihan, C.; Adams, M.E.; Froehner, S.C. 1999: Beta2-Syntrophin at glutamatergic synapses in the outer plexiform layer of the rodent retina. Society for Neuroscience Abstracts 25(1-2): 1279

Moran, E.J.; Griffin, J.H.; Choi, S.K. 2003: Beta2-adrenergic receptor agonists. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)

Johnson, J.A.; Thomason, D.B.; Mohamed, M.H.N.; Self, T.H.; Eberle, L.V.; Lima, J.J. 1999: Beta2-adrenergic receptor polymorphism affects albuterol concentration -response relationship in asthmatics. Clinical Pharmacology and Therapeutics 65(2): 144

Buescher, R.; Grasemann, H.; Eilmes, K.J.; Insel, P.A.; Ratjen, F. 2001: Beta2-adrenergic receptor polymorphisms and altered lung function in cystic fibrosis. FASEB Journal 15(4): A220

Metra, M.; Nodari, S.; Pezzali, N.; Covolo, L.; Gelatti, U.; Donato, F.; Nardi, G.; Dei Cas, L. 2003: Beta2-adrenergic receptor polymorphisms influence the resting and exercise haemodynamics in the patients with chronic heart failure. European Heart Journal 24(Abstract Suppl): 247

Forleo, Cinzia; Resta, Nicoletta; Sorrentino, Sandro; Guida, Pietro; Manghisi, Andrea; De Luca, Viviana; Romito, Roberta; Iacoviello, Massimo; Massari, Francesco; Rizzon, Brian; Guanti, Ginevra; Rizzon, Paolo 2003: Beta2-adrenergic receptor polymorphisms predict heart failure progression in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology 41(6 Suppl A): 201A

Turner, N.A.; Porter, K.E.; Ball, S.G.; Balmforth, A.J. 2003: Beta2-adrenergic receptor stimulation increases human cardiac fibroblast proliferation via an endothelin 1-dependent autocrine mechanism. European Heart Journal 24(Abstract Suppl): 332

Nakamura, A.; Johns, E.J.; Imaizumi, A.; Yanagawa, Y.; Kohsaka, T. 2001: Beta2-adrenoceptor activation inhibits shiga toxin-induced TNF-alpha production in renal tubular epithelial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 177A

Sato, M.; Terracciano, C.M.; Ranu, H.K.; Harding, S.E. 2003: Beta2-adrenoceptor coupling to the Na/Ca exchanger depresses contraction in adult rat ventricular myocytes. Circulation 108(17): IV179-IV180

Meirhaeghe, A.; Helbecque, N.; Cottel, D.; Amouyel, P. 1999: Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 353(9156): 896

Kaye, D.M.; Smirk, B.; Williams, C.; Esler, M.; Jennings, G.; Holst, D. 2002: Beta2-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Circulation 106(19): II611

Humma, L.M.; Nguyen, B.N.; Farmerie, W.G.; Wallace, M.R.; Johnson, J.A. 2000: Beta2-adrenoceptor polymorphisms are associated with nocturnal blood pressure decline in hypertensives. Journal of the American College of Cardiology 35(2 Suppl A): 333A

Laliberte, R.; L'ecuyer, Y. 2003: Beta2-agonists versus corticosteroids Myth or reality Another debate. Journal of Clinical Pharmacology 43(9): 1024

Chess Williams, R.; Yamanishi, T.; Yasuda, K.; Chapple, C.R. 2001: Beta2-and beta3-adrenoceptors mediate relaxation in pig detrusor muscle. European Urology 39(Suppl 5): 129

Williams, F.K.; Jurd, K.M.; Hughes, G.R.; Hunt, B.J. 1999: Beta2-glycoprotein I alters the functional expression of tissue factor. Arthritis and Rheumatism 42(9 Suppl): S371

Harats, D.; George, J.; Gilburd, B.; Afek, A.; Shaish, A.; Shoenfeld, Y. 1999: Beta2-glycoprotein I as an influencial determinant in atherosclerosis. Journal of Autoimmunity (Suppl ): 7

Matsuda, J.; Gohchi, K.; Gotoh, M.; Kawasugi, K.; Katoh, M. 1999: Beta2-glycoprotein I-dependent anticardiolipin antibody is reactive to both beta2-glycoprotein I/oxidized as well as beta2-glycoprotein I/reduced cardiolipin. Thrombosis Research 95(1): 63-67

Leitner, K.; Szlauer, R.; Unterberger, U.; Schwab, M.; Ellinger, I.; Ellinger, A.; Fuchs, R. 1999: Beta2-microglobulin and hFcRn expression in human placental syncytiotrophoblast. Placenta 20(5-6): A 42

Rampino, T.; Ranghino, A.; Gregorini, M.; Guallini, P.; Maggio, M.; Soccio, G.; Bellotti, V.; Pignatti, P.; Massa, M.; Dal Canton, A. 1999: Beta2-microglobulin expressed on peripheral blood mononuclear cells changes conformation during hemodialysis. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 300A

Koene, G.; Coenen, S.; Verdaasdonk, M.; De Weger, R.; Slootweg, P.; Tilanus, M. 2002: Beta2-microglobulin expression and LOH in head and neck squamous cell carcinoma. European Journal of Immunogenetics 29(2): 144

Hurd, T.C.; Hylander, B.L.; Winston, J.; Lankes, H.; Repasky, E. 2000: Beta2-microglobulin expression in primary and passaged human breast tumors in the SCID mouse. Immunological Investigations 29(2): 215

Wu, C.H.; Gordon, J.D.; Rastegar, M.; Safa, A.R. 2001: Beta2-microglobulin induces apoptosis in several sensitive and P-glycoprotein or MRP containing multidrug resistant cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 42: 441

Chen, X.; Wu, Z.; Yu, S.; Wang, S.; Peng, X. 2010: Beta2-microglobulin is involved in the immune response of large yellow croaker to Aeromonas hydrophila: a proteomic based study. Fish and Shellfish Immunology 28(1): 151-158

Krieter, D.H.; Mueller Groh, F.; Reinhardt, B.; Sauer, N.; Brandt, T.; Lemke, H.D.; Canaud, B.; Quellhorst, E. 2001: Beta2-microglobulin removal and albumin loss in hemodiafiltration Comparison of three high-flux hemodiafilters. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 358A

Larsen, T.M.; Buemann, B.; Toubro, S.; Astrup, A. 2001: Beta2-receptor polymorphism Gln27Glu associated with 24 h spontaneous physical activity. International Journal of Obesity 25(Suppl 2): S13

Gonzalez Sanchez, J.L.; Proenza, A.M.; Martinez Larrad, M.T.; Ramis, J.M.; Fernandez, C.; Gabriel, R.; Palou, A.; Serrano Rios, M.; Spanish Insulin Resistance Study Group 2000: Beta2/beta3 Adrenergic receptor genes polymorphism in the general population of Spain according to BMI and degree of glucose tolerance. International Journal of Obesity 24(Suppl 1): S36

Donohoe, S.; Kingdom, J.; Mackie, I.; Jauniaux, E.; Machin, S. 1999: Beta2GPI and annexin V in normal and APS villous placenta. British Journal of Haematology 105(Suppl 1): 28

Cao, W.; Wang, L.; Mu, J.; Sun, G.; Lu, Y.; Li, X.; Li, W.; Yang, H. 2000: Beta2GPI recognizing molecules identified by using phage display peptide library technique. Journal of Autoimmunity 15(2): A90

Jaradat, M.; Schnizlein Bick, C.; Singh, G.; Bailey, A.; Addington, K.; Shoufler, D.; Moe, S. 1999: Beta2M, but not AGE-beta2M, induces the expression of intercellular and vascular adhesion molecules in human synovial fibroblasts. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 285A

Gallon, L.; Mcdermott, D.H.; Huong, T.T.; Rubel, J.R.; Kaufman, D.; Leventhal, J.; Milford, E.L.; Abdi, R. 2002: Beta3 Integrin PlA1 homozygotes are at increased risk of acute rejection in human renal transplantation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 184A

Weng, S.; Zemany, L.; Standley, K.N.; Novack, D.V.; La Regina, M.; Bernal-Mizrachi, C.; Coleman, T.; Semenkovich, C.F. 2003: Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice. Proceedings of the National Academy of Sciences of the United States of America 100(11): 6730-6735

Morgan, K.; Stevens, E.B.; Shah, B.S.; Cox, P.J.; Dixon, A.K.; Lee, K.; Richardson, P.J.; Pinnock, R.D.; Mizuguchi, K.; Jackson, A.P. 2000: Beta3 Is a novel auxiliary subunit for voltage-gated sodium channels which exhibits a complimentary distribution to beta1 in adult rat. Journal of Physiology (Cambridge) (523P): 159P-160P

Khan, I.F.; Hullin, R.; Herzig, S. 2002: Beta3 Subunits cloned from human heart modulate single recombinant Cav12a and Cav12b pore-forming subunits of the L-type calcium channel. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R59

Evers, B.; Jesudason, C.D.; Karanjawala, R.E.; Remick, D.M.; Sall, D.J.; Siegel, M.G.; Stenzel, W.; Stucky, R.D.; Werner, J.A. 2004: Beta3 adrenergic agonists. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Day, R.F.; Lafontaine, J.A. 2003: Beta3 adrenergic receptor agonists and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1270(3)

Granneman, J.G. 2000: Beta3 adrenergic receptors as a therapeutic target for obesity. Lockwood, D H Author, Heffner, T G Author Handbook of Experimental Pharmacology Obesity: Pathology and therapy 343-367

Shuker, A.J.; Bell, M.G.; Bloomquist, W.; Calligaro, D.O.; Cohen, M.L.; Crowell, T.A.; Cusick, T.S.; Droste, C.A.; Evrard, D.A.; Hahn, P.J.; Heiman, M.L.; Jesudason, C.D.; Jones, C.D.; Kim, G.; Kriauciunas, A.V.; Matthews, D.P.; Mcdonald, J.H.; Neel, D.A. 1999: Beta3 receptor agonists for the treatment of obesity. Abstracts of Papers American Chemical Society 217(1-2): MEDI 159

Morgan, K.; Stevens, E.B.; Shah, B.S.; Cox, P.J.; Dixon, A.K.; Lee, K.; Richardson, P.J.; Pinnock, R.D.; Mizuguchi, K.; Jackson, A.P. 2000: Beta3, A novel voltage-gated sodium channel beta subunit, modulates alphaIIA channel gating in Xenopus oocytes. Journal of Physiology (Cambridge) (523P): 160P-161P

Shah, B.S.; Gonzalez, M.I.; Bramwell, S.; Pinnock, R.D.; Lee, K.; Dixon, A.K. 2000: Beta3, a novel auxiliary subunit for the voltage gated sodium channel is upregulated in sensory neurones in the chronic constriction injury model of neuropathic pain. European Journal of Neuroscience 12(Suppl 11): 70

Thai, H.M.; Do, B.; Huang, R.; Spooner, P.; Indyk, J.; Goldman, S.; Gaballa, M. 2004: Beta3-Adrenergic receptor activation decreases peripheral vascular resistance in heart failure by restoring endothelial dependent vasorelaxation via endothelial nitric oxide synthase upregulation. Journal of the American College of Cardiology 43(5 Suppl A): 220A

Nisoli, E.; Tonello, C.; Carruba, M.O. 2003: Beta3-Adrenergic receptors Really relevant targets for anti-obesity drugs?. Current Medicinal Chemistry - Central Nervous System Agents 3(3): 257-273

Inoue, A.; Tobe, K.; Suzuki, R.; Aoyama, M.; Kowatari, N.; Yoshimatsu, H.; Kato, H.; Kadowaki, T. 2003: Beta3-Adrenoceptor agonist treatment ameliorated leptin resistance in Irs2-/- mice. Diabetes 52(Suppl 1): A388

Brixius, K.; Bloch, W.; Pott, C.; Krahwinkel, A.; Mehlhorn, U.; Schwinger, R.H.G. 2002: Beta3-Adrenoceptor mediated eNOS-activation reduces cardiac contractility by stimulation of the AKT-kinase. European Heart Journal 23(Abstract Suppl): 253

Dessy, C.; Moniotte, S.L.I.; Noirhomme, P.; Balligand, J.L.c 2000: Beta3-Adrenoceptor stimulation evokes a relaxation of human coronary microarteries. Circulation 102(18): 2; 230

Conrath, C.E.; Opthof, T. 2002: Beta3-Adrenoceptors in the heart. Cardiovascular Research 56(3): 353-356

Leblais, V.; Escande, D.; Gauthier, C. 1999: Beta3-Adrenoceptors regulate CFTR conductance through a PTX-sensitive G protein. Circulation 100(18): 1; 488

Proenza, A.M.; Gonzalez Sanchez, J.L.; Ramis, J.M.; Martinez Larrad, M.T.; Palou, A.; Serrano Rios, M. 2001: Beta3-Adrenoreceptor and uncoupling protein-1 polymorphisms in the general population of Spain. International Journal of Obesity 25(Suppl 2): S45

Hennet, T.; Berger, E.G. 2002: Beta3-Galactosyltransferase-I, -II, and -III. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 27-32

Haltiwanger, R.S. 2002: Beta3-N-Acetylglucosaminyltransferase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 107-113

Cheng, C.P.; Ukai, T.; Onishi, K.; Zhang, Z.S.; Cheng, H.J.; Tachibana, H. 1999: Beta3-adrenergic activation-induced enhanced cardiac depression in heart failure Assessment by left ventricular pressure-volume analysis. Circulation 100(18): 1; 552

Krzyaniak, J.F.; Lafontaine, J.A. 2004: Beta3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Skeberdis, V.A.; Jurevicius, J.; Fischmeister, R. 1999: Beta3-adrenergic regulation of L-type Ca2+ current in human atrial myocytes. Biophysical Journal 76(1 Part 2): A343

Klein, J.; Fasshauer, M.; Kahn, C.R.nald 1999: Beta3-adrenergic stimulation inhibits insulin signaling at different levels and decreases insulin-induced glucose uptake in brown adipocytes. Diabetes 48(Suppl 1): A339

Mizuno, K.; Kanda, Y.; Kuroki, Y.; Watanabe, Y. 2000: Beta3-adrenoceptor agonists induce ERK1/2 phosphorylation via a PTX-insensitive G protein-dependent pathway in 3T3-L1 adipocytes. Japanese Journal of Pharmacology 82(Suppl 1): 43P

Jimenez, M.; Giovannini, N.; Lehr, L.; Giacobino, J.P.; Seydoux, J.; Assimacopoulos, F.; Preitner, F.; Muzzin, P. 2003: Beta3-adrenoceptor knockout in C57BL/6J mice on a high fat diet depresses the insulin response to glucose. International Journal of Obesity 27(Suppl 1): S51

Herrera, E.; Crespo, D.; Ramos, P. 2000: Beta3-adrenoceptors in adipose tissue are modulated by hyperinsulinemia and insulin sensitivity during pregnancy. Diabetologia 43(Suppl 1): A215

Feller, D.R.; Miller, D.D. 2003: Beta3-adrenoreceptor agonists, agonist compositions and methods of making and using the same. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)

Furukawa, K.; Clausen, H. 2002: Beta4-Galactosyltransferase-II, -III, -IV, -V, -VI, and -VII. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 20-26

Furukawa, K. 2002: Beta4-N-Acetylgalactosaminyltransferase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 174-179

Jeddi, P.A.; Lydyard, P.M.; Delves, P.J. 2000: Beta4Gal-T1 expression following prolactin stimulation of B-cells. Glycoconjugate Journal 17(1-2): 80

Chen, J.; Moloney, D.J.; Stanley, P. 2001: Beta4Galactosyltransferase-I is required for fringe modulation of Jagged1-induced notch signaling. Glycobiology 11(10): 864

Fukuda, M. 2002: Beta6-N-Acetylglucosaminyltransferase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 125-132

D'adamio, L. 2002: BetaAPP processing, its biology and Alzheimers Disease. Israel, A , Reprint Author, DeStrooper, B, Checler, F, Christen, Y Notch from neurodevelopment to neurodegeneration: Keeping the fate: 101-108

Suzuki, Y.; Nakano, K.; Sugiyama, M.; Matsumoto, Y.; Imagawa, J.I.; Ikeda, S. 2002: BetaARK1 inhibition improves survival and cardiac function in a mouse model of heart failure induced by myocardial infarction. Circulation 106(19): II291

Harding, V.B.; Rapacciuolo, A.; Mao, L.; Lefkowitz, R.J.; Rockman, H.A. 1999: BetaARK1 inhibition improves survival and cardiac function in a mouse model of severe cardiomyopathy. Circulation 100(18): 1; 552

Eckhart, A.D.; Iaccarino, G.; Koch, W.J. 1999: BetaARK1 targeted expression in vascular smooth muscle of transgenic mice. Circulation 100(18): 1; 487

Klink, A.; Sani, S.; Daffner, K.R.; Kuznetsov, D.; Wu, C.K.; Geula, C. 1999: Beta Amyloid deposits in the aged rhesus brain Distribution, progression and chemical signature. Society for Neuroscience Abstracts 25(1-2): 2052

Geula, C.; Sani, S.; Klink, A.; Wu, C.K.; Kuznetsov, D. 1999: Beta Amyloid deposits in the aged rhesus brain Pathological effects. Society for Neuroscience Abstracts 25(1-2): 2052

Gold, E.J.; Francis, R.J.B.; Wheatley, A.M.; Fleming, J.S. 2001: BetaC-activin and betaE-activin mRNA levels increase during the development of CCl4-induced cirrhosis in the rat. Molecular and Cellular Endocrinology 180(1-2): 190

Degani, G.; Jackson, K.; Goldberg, D.; Sarfati, R.; Avtalion, R.R. 2003: BetaFSH, betaLH and growth hormone gene expression in blue gourami during spermatogenesis and male sexual behavior. Zoological Science (Tokyo) 20(6): 737-743

Honke, K. 2002: BetaGal 3-O-sulfotransferase-1, -2, -3, and -4. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 501-508

Lei, H.Q.; Choi, E.; Maron, D.; Stark, G.R.; Fraker, D.L.; Wilson, J.M.; Spitz, F.R. 2000: BetaIFN induced apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 41: 738

Bohlen, H.G.; Nase, G.P. 2000: BetaII protein kinase inhibition prevents and reverses in vivo endothelial nitric oxide suppression during acute hyperglycemia. FASEB Journal 14(4): A27

Berghs, S.A.; Aggujaro, D.; Dirkx, R.; Maksimova, E.; Solimena, M. 2000: BetaIV spectrin, a new spectrin localized at axon initial segments and nodes of Ranvier. Molecular Biology of the Cell 11(Suppl): 547a-548a

Solimena, M.; Berghs, C.A.F.M.; Dirkx, R.A. 2001: BetaIV-spectrin-polypeptides and nucleic acids encoding same. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)

Park, D.; Rhee, S.; Yang, S.; Lee, S.J.; Kim, C.; Lee, D. 2001: BetaPix-bL, a novel isoform generated by alternative translation, regulates cellular vesicle development. Molecular Biology of the Cell 12(Suppl): 343a-344a

D.L.T.rre, M.M.; San Roman, J.A.; Bermejo, J.; Pastor, G.; Alonso, J.; Fernandez Aviles, F. 2000: Betablockade and dobutamine-echocardiography risk stratification after acute myocardial infarction. European Heart Journal 21(Abstract Suppl): 111

Stuehlinger, H.G.; Gamper, G.; Herkner, H.; Thell, R.; Havel, C.; Wachek, V.; Laggner, A.N. 2001: Betablockers in patients with thrombolysis Does it make sense?. European Heart Journal 22(Abstract Suppl): 545

D.L.zio, S.; Gorini, M.; Opasich, C.; Porcu, M.; Tavazzi, L.; Maggioni, A.P. 2002: Betablockers use in severe and old patients with heart failure Data from BRING-UP 2 Study. European Heart Journal 23(Abstract Suppl): 395

Mifune, M.; Frank, G.D.; Dempsey, P.J.; Inagami, T.; Eguchi, S. 2003: Betacellulin stimulates proliferation and migration of vascular smooth muscles cells via ErbB1/ErbB2 receptors signal transduction. FASEB Journal 17(4-5): Abstract 130

Ferguson, J.W.; Fiedler, M.A.; Lebaron, R.G. 2000: Betaeta-jg expression in eye tissue during murine development. IOVS Investigative Ophthalmology and Visual Science 41(4): S7

Freedman, M.S.; Edan, G.; Hartung, H.P.; Kappos, L.; Miller, D.; Montalban, X.; Polman, C.; Barkhof, F.; Bauer, L.; Ghazi, M.; Sandbrink, R. 2003: Betaferon /Betaseron in early treatment of multiple sclerosis The benefit study. Neurology 60(5 Suppl 1): A483

Vale, W.; Lewis, K.A.; Gray, P.C.; Bilezikjian, L.M.; Blount, A.L. 2004: Betaglycan as an inhibin receptor and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1279(3)

Gray, P.C.; Lewis, K.A.; Blount, A.L.; Bilezikjian, L.M.; Vale, W. 2001: Betaglycan forms a high-affinity complex with inhibin and the type II activin receptor and can mediate functional antagonism of activin signaling. Molecular and Cellular Endocrinology 180(1-2): 196

Griffiths, P.D. 1999: Betaherpesviruses in transplant patients. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 33

Mira, E.; Valli, S.; Botta, L.; Perin, P.; Zucca, G.; Benvenuti, C.; Guth, P.; Valli, P. 2000: Betahistine and vertigo Effects of the drug on peripheral vestibular system. Claussen, Claus-Frenz , Haid, Claus-Toni , Hofferberth, Bernhard International Congress Series; Equilibrium research, clinical equilibriometry and modern treatment 539-542

Paul, L.C. 2001: Beta(ig) H-3: why should we know about this molecule?. Transplantation 72(11): 1725-1726

Derubeis, A.R.; Dieudonne, S.C.; Kim, I.S.; Kuznetsov, S.A.; Robey, P.G.; Young, M.F. 1999: Betaig-h3 A matrix protein important in bone formation?. Journal of Bone and Mineral Research 14(Suppl 1): S441

Mccollum, G.W.; Yang, R.; Araki Saski, K.; Munier, F.L.; Schorderet, D.F.; Wang, M.X. 1999: Betaig-h3 mRNA levels are transforming growth factor-beta-responsive and cell density dependent in an SV40-immortalized human corneal epithelial cell line. IOVS Investigative Ophthalmology and Visual Science 40(4): S759

Kim, I.S.; Kim, J.E.; Choi, M.H.; Bae, Y.C.; Kim, E.H.; Choi, H.M. 1999: Betaig-h3, a new TGF-beta induced cell adhesion molecule expresses in chondrocytes in the hypertrophic cartilage zone and polymerizes to form a fibrillar structure. Journal of Bone and Mineral Research 14(Suppl 1): S187

Akula, A.; Akula, C.; Bateson, M. 2000: Betaine a novel candidate for rapid induction of somatic embryogenesis in tea O Kuntze. Plant Growth Regulation 30(3): 241-246

Culham, D.E.; Jishage, M.; Ishihama, A.; Wood, J.M. 1999: Betaine accumulation and osmoadaptation by Escherichia coli Basis for an alternative approach to the treatment of urinary tract infections?. Abstracts of the General Meeting of the American Society for Microbiology 99: 61

Kilibwa, M. 2001: Betaine and bakery products. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)

Houghton, W.C. 2003: Betaine and nonalcoholic steatohepatitis. American Journal of Gastroenterology 98(12): 2803

Chosa, J.; Tomita, T.; Kelland, M.A.drew 2002: Betaine compound and process for production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Zhang, L.; Hao, C.M.; Breyer, M.D.; Moeckel, G.W. 2003: Betaine decreases hyperosmotic stress-induced cytochrome c release in medullary interstitial cells. Journal of the American Society of Nephrology 14(Abstracts Issue): 72A

Balkenhol, N.D.; Laryea, M.D.; Hafner, D.; Wendel, U.; Schwahn, B.C. 2003: Betaine effects on severe hyperhomocysteinemia. Journal of Inherited Metabolic Disease 26(Suppl 2): 72

Abdelmalek, M.F.; Angulo, P.; Jorgensen, R.A.; Sylvestre, P.B.; Lindor, K.D. 2000: Betaine for the treatment of nonalcoholic steatohepatitis A promising new agent. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A973

Forestier, M.; Bänninger, R.; Reichen, Jürg.; Solioz, M. 2003: Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. Biochimica et Biophysica Acta 1638(1): 29-34

Steen, M.T.; Kruger, W.D.; Singh, R.H.; Pasquali, M.; Elsas, L.J.II 2000: Betaine increases methionine/homocysteine ratios and decreases total plasma homocysteine in cystathionine beta-synthase deficiency. Journal of Inherited Metabolic Disease 23(Suppl 1): 61

Shi, Q-Zhao.; Wang, L-Wen.; Zhang, W.; Gong, Z-Jiong. 2010: Betaine inhibits toll-like receptor 4 expression in rats with ethanol-induced liver injury. World Journal of Gastroenterology 16(7): 897-903

Baltz, J.M.; Hammer, M.A.ne 2002: Betaine is transported into 1-cell mouse embryos via a novel transport mechanism and functions as an organic osmolyte. Biology of Reproduction 66(Suppl 1): 104

Johnson, T.N.; Rostami Hodjegan, A.; Matthews, A.; Tucker, G.T.; Bonham, J. 2001: Betaine kinetics in man. British Journal of Clinical Pharmacology 51(4): 386P-387P

Dellow, W.J. 2000: Betaine metabolism in health and disease. Biochemical Society Transactions 28(5): A155

Ogborn, M.R.; Evan, N.; Neda, B.C.; House, J. 2001: Betaine normalizes early hyperhomocysteinemia in the HanSPRD-cy rat. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 822A

Ogborn, M.R.; Nitschmann, E.; Bankovic Calic, N.; Buist, R.; Peeling, J. 1999: Betaine normalizes hepatic metabolism in uremic rats. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 666A-667A

Moilanen, R.; Hallanoro, H. 2002: Betaine product, method for its manufacture, and its use. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)

Halamicek, D.; Sorrell, M.F.; Tuma, D.; Melvor, C. 1999: Betaine protects against transforming growth factor beta-induced apoptosis in primary rat hepatocytes. Journal of Investigative Medicine 47(7): 233A

Brouwer, I.A.; Verhoef, P.; Urgert, R. 2000: Betaine supplementation and plasma homocysteine in healthy volunteers. Archives of Internal Medicine 160(16): 2546-2547

McGregor, D.O.; Dellow, W.J.; Robson, R.A.; Lever, M.; George, P.M.; Chambers, S.T. 2002: Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney International 61(3): 1040-1046

Kremer, J.M.; Mroczkowski, P.; Kelly, S.; Hausner, D.; Nami, A.; Hall, M.J.; Harris, E.M.; Lawrence, D.A. 1999: Betaine supplementation in patients with rheumatoid arthritis on MTX is associated with a decrease in homocysteine and increases in methionine, IL-2, and TNFalpha Clues to how MTX acts. Arthritis and Rheumatism 42(9 Suppl): S380

Iles, R.A.; Murphy, H.C.; Bain, M.D.; Chalmers, R.A. 2001: Betaine therapy in homocystinuria Metabolic and clinical considerations. Journal of Inherited Metabolic Disease 24(Suppl 1): 48

Delgado Reyes, C.V.; Garrow, T.A. 2003: Betaine-homocysteine S-methyltransferase is regulated by tonicity in vivo. FASEB Journal 17(4-5): Abstract 449

Martin, A.; Berkompas, J.L.; Stanislaw, S.; Runyan, R.B. 2003: Betaine-homocysteine methyltransferase is expressed in the embryonic heart and may be protective against congenital heart disease. FASEB Journal 17(4-5): Abstract 468

Salisbury, E.; Castro, C.; Garrow, T.A. 2001: Betaine-homocysteine methyltransferase transcription is inhibited by supplementing human hepatoma cell culture media with S-adenosylmethionine. FASEB Journal 15(4): A289

Thornton, C.G. 2002: Betaines as adjuvants to susceptibility testing and antimicrobial therapy. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Gershanovich, M.L.; Filatova, L.V.; Ketlinsky, S.A.; Simbirtsev, A.S. 2000: Betaleukin - a newly-developed effective stimulator and protector of leukopoiesis involved in combination chemotherapy of malignant tumors. Voprosy Onkologii (St Petersburg) 46(3): 354-360

Axelsson, P.; Thörn, S.E.; Wattwil, M. 2004: Betamethasone does not prevent nausea and vomiting induced by ipecacuanha. Acta Anaesthesiologica Scandinavica 48(10): 1283-1286

Goldkrand, J.; Leff, R. 2001: Betamethasone suppression of salivary estriol. American Journal of Obstetrics and Gynecology 184(1): S34

Housman, T.S.; Mcmichael, A.J.; Mellen, B.G.; Derrow, A.E.; Mccarty, M.A.; Feldman, S.R. 2002: Betamethasone valerate foam vs fluocinolone acetonide topical oil in the treatment of scalp psoriasis Quantitative assessment of patients preference and efficacy. Journal of Investigative Dermatology 119(1): 241

Donati, E.; Rapaport, I. 2002: Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis. Official Gazette of the United States Patent and Trademark Office Patents 1257(5)

Chopyak, V.; Fedorov, Y.U.; Synenkyi, O.; Valchuk, I. 2001: Betamethazon influence on myeloperoxidase activity and L-arginine metabolism in patients with urticarial vasculitis. Allergy 56(Suppl 68): 156-157

Ristaldi, M.S.; Cao, A.; Porcu, S. 2003: Betamin globin gene expression is preferentially reduced in EKLF KO mice. Blood 102(11): 32b

Griffioen, A.W.; Van Der Schaft, D.W.J.; Cox, A.; Visentin, G.; Barendsz Janson, A.F.; Struijker Boudier, H.; Hillen, H.F.P.; Mayo, K.H. 1999: Betapep-25, A designed peptide cytokine that inhibits angiogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 40: 65

Boĭko, A.N.; Derevianko, S.N.; Luchikhin, L.A.; Slanova, A.V.; Gusev, E.I. 2002: Betaserc in symptomatic therapy of multiple sclerosis. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(1): 42-45

Tombul, T.; Atbas, C.; Anlar, O.; Tanik, O. 2001: Betathromboglobulin and platelet factor-4 as platelet activating factors in ischaemic stroke, and their relationship with type of stroke, risk factors and disability. European Journal of Neurology 8(Suppl 2): 9

Collier, R.J.; Landers, R.; Martin, E.A.; Agarwal, N.; Kapin, M.A. 2000: Betaxolol and its isomers are neuroprotective in a photic retinopathy model. IOVS Investigative Ophthalmology and Visual Science 41(4): S187

Sato, T.; Yamada, K.; Kitada, Y. 2001: Betaxolol decreases endothelial oxygen radical production and mortality, and improves cardiac myofilament function in streptozotocin -induced diabetic rat Comparison with the effects of enalapril. Journal of Molecular and Cellular Cardiology 33(6): A106

Latz, C.; Osborne, N.N.; Mergler, S. 2001: Betaxolol decreases the rise in NMDA mediated intracellular calcium influx in human retinal ganglion cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S836

Sun, D.; Rait, J.L.; Kalloniatis, M. 2001: Betaxolol inhibits NMDA gated labelling in retinal neurons. IOVS Investigative Ophthalmology and Visual Science 42(4): S749

Bron, A.J.; Stanton, D.; Osborne, N.N.; Melena, J. 2000: Betaxolol interacts with calcium channels Relevance to glaucoma. IOVS Investigative Ophthalmology and Visual Science 41(4): S829

Osborne, N.N.; Melena, J.; Chidlow, G. 2000: Betaxolol reduces sodium influx into cortical neurons by direct interaction with sodium channels Comparison with other beta-adrenoceptor antagonists. IOVS Investigative Ophthalmology and Visual Science 41(4): S830

Deedwania, P.C.; Carbajal, E.; Oakley, J. 1999: Betaxolol, a new, long-acting beta-blocker, suppresses intraoperative myocardial ischemia during vascular surgery in patients with preoperative ischemia and coronary artery disease. Journal of the American College of Cardiology 33(2 Suppl A): 281A

Riedl, C.; Daha, L.; Knoll, M.; Pflueger, H. 2003: Bethanechol for the treatment of neurogenic detrusor contractility disorders A prospective, randomised, double-blind, placebo-controlled, crossover clinical Trial. European Urology Suppls 2(1): 171

Riedl, C.; Daha, L.; Knoll, M.; Pflueger, H. 2002: Bethanechol in the restitution of the acontractile detrusor A prospective, randomized, double-blind, placebo-controlled study. Neurourology and Urodynamics 21(4): 376

Smith, J.H.F. 2002: Bethesda 2001. Cytopathology: Official Journal of the British Society for Clinical Cytology 13(1): 4-10

Geana, M.V.; Cameron, G. 2004: Better Nurses for Better Care Nurse-Patient Communication about Functional Foods as a Trigger for Personal and Professional Gain. FASEB Journal 18(4-5): Abstract 111

Abrahamsen, J.F.; Rusten, L.; Bakken, A.M.; Bruserud, O. 2002: Better Preservation of Early Hematopoietic Progenitor Cells When Peripheral Blood Progenitor Cells Are Cryopreserved with 5% as Compared to 10% DMSO. Blood 100(11): Abstract No. 2436

Diaz Gomez, N.M.; Domenech, E.; Abad, F.; Robayna, M.; Gonzalez, D.; Feria, M. 2001: Better analgesic effect of oral sucrose than EMLA cream during venipuncture in neonates. Pediatric Research 49(2): 310

Simon, R.; Lins, M.; Herrmann, G.; Krueger, D.; Plate, V. 2002: Better angiographic images at lower Xray dose with an integrated flat panel detector. European Heart Journal 23(Abstract Suppl): 607

Mueller Richter, U.D.; Ruprecht, K.W. 2001: Better assessment of scanning laser tomography through three-dimensional spatial presentation. IOVS Investigative Ophthalmology and Visual Science 42(4): S18

Elliott, W.J. 2002: Better blood pressure response in patients with ACE-inhibitor-associated cough. American Journal of Hypertension 15(4 Part 2): 43A

Greenwald, M.; Barajas, K. 2000: Better bone density reporting T score report versus fracture report with outcome analysis. Journal of Bone and Mineral Research 15(Suppl 1): S401

Schulze, J.; Rothe, U.; Mueller, G.; Kunath, H.; Fachkommission Diabetes Sachsen 2003: Better care for diabetics with the care model used in Saxony. DMW Deutsche Medizinische Wochenschrift 128(21): 1161-1166, 23 Mai

Golombek, S.G.; Berning, F.; La Gamma, E.F. 2002: Better compliance and fewer hospitalizations with RSV prophylaxis in a home setting. Journal of Investigative Medicine 50(2): 184A

Marwick, C. 1999: Better control coming for clotting and bleeding. JAMA 282(16): 1509-1510

Camerini, C.; Capistrano, M.; Movilli, E.; Gaggia, P.; Brunori, G.; Cancarini, G.C.; Maiorca, R. 2001: Better control of hypercalcemia and hyperphosphatemia with a single weekly dose of calcitriol. Nephrology Dialysis Transplantation 16(6): A176

Nieto, J.; Gomez Campdera, F.; Rodriguez Perez, J.C.; Robles, R.; Calvo, C.; Garcia Puig, J.; Martin Hidalgo, A.; Ruilope, L.M.; Garrido, J.; Tisaire, J. 1999: Better control of hypertensive type 2 diabetic patients with albuminuria A prospective randomized double-blind trial. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 131A

Silberberg, J. 1999: Better coronary risk assessment in women. Lancet 353(9165): 1637-1638

Froelicher, V.; Shetler, K.; Ashley, E. 2002: Better decisions through science: exercise testing scores. Progress in Cardiovascular Diseases 44(5): 395-414

Deltoro, C.; Woods, C.; Glock, M.; Hill, I.; Georgitis, J. 1999: Better definitions of pharyngeal acid reflux in children. Journal of Allergy and Clinical Immunology 103(1 Part 2): S196

Bussey, H. 2001: Better delivery of standard antithrombotic care. American Heart Journal 141(6): 1038-1042

Linkeschova, R.; Raoul, M.; Bott, U.; Berger, M.; Spraul, M. 2000: Better diabetes control, quality of life and less severe hypoglycaemias with insulin pump treatment. Diabetologia 43(Suppl 1): A195

Mark, T.L.; Mckenzie, S.R.; Piech, C.T. 2003: Better early and overall hematologic outcomes and lower drug cost with epoetin alfa compared with darbepoetin alfa. Blood 102(11): 510b

Bisioli, C.; Valcarcel, A.; Tiveron, M.; Quintana, R.; Young, E.; Sueldo, C. 2003: Better embryo quality and reproductive performance using sequential media in day 3 transfers. Fertility and Sterility 80(Suppl 3): S57

Deng, X.W.; Mcnellis, T.; Torii, K. 2003: Better emergence characteristics and improved seedling growth under low-light environments. Official Gazette of the United States Patent and Trademark Office Patents 1271(3)

Puri, R.; Eisenberg, M.J.; Pilote, L.; Blankenship, J.C.; Cugno, S.; Huynh, T. 2003: Better functional status among US than non-US patients after percutaneous coronary intervention An effect of medical care?. Journal of the American College of Cardiology 41(6 Suppl A): 521A

Garg, S.K.; Anil, S.; Gottlieb, P.; Mackenzie, T.; Jackson, W.E. 2001: Better glycemic control and reduced need for caesarian sections with insulin lispro treated pregnancies in type 1 diabetes. Diabetes 50(Suppl 2): A383

Jabbour, S.; Lown, B. 2002: Better hypertension control? Not without broad interventions by strong public health institutions. Archives of internal medicine 162(13): 1530-1; author reply 1531

Sebestjen, M.; Keber, I.; Zegura, B.; Simsic, S.; Fressart, M.; Stegnar, M. 2002: Better influence of statin than of fibrate on novel risk factors in combined hyperlipidemia. European Heart Journal 23(Abstract Suppl): 17

Kjell, G. 2003: Better integration of environmental and fisheries science for management advice. Estuarine Coastal and Shelf Science 56(3-4): 411-413

Oudkerk, M.; Van Dijk, P.; Torres, C.G.; Konig, M.; Grimm, J.; Op De Beeck, B.; Fernandez Cuadrado, J.; Roddie, M.; Song, B. 2000: Better liver lesion diagnosis with mangafodipir trisodium -enhanced MR liver imaging A multicenter study comparing MR and biphasic spiral CT. Journal of Hepatology 32(Suppl 2): 136

Sims, J.Jason.; Ujhelyi, M.R. 2004: Better living through medical device technology. PharmacoTherapy 24(2): 298-305; Discussion 305-6

Lin, R.; Nahal, A.; Lee, M.; Menikoff, H. 2000: Better nasal cytologic distinctions between clinical groups using the Rhinoprobe compared to the cytobrush. Journal of Allergy and Clinical Immunology 105(1 part 2): S196

Roger, L. 2000: Better observational studies make better economic evaluations. Journal of Rheumatology 27(8): 2052-2053

Lagerqvist, B.; Husted, S.; Kontny, F.; Stahle, E.; Swahn, E.; Wallentin, L. 2001: Better outcome after 2 years with an early invasive strategy in unstable coronary artery disease FRISCII 2 year follow-up. Circulation 104(17): 2; 547

A.R.yyes, O.; Oqvist, B. 2001: Better outcome of renal graft function in diabetics than in non-diabetics. Nephrology Dialysis Transplantation 16(6): A77

Brensing, K.A.; Schepke, M.; Perz, J.; Textor, J.; Schiedermaier, P.; Raab, P.; Kramer, H.J.; Klehr, H.U.; Schild, H.; Sauerbruch, T. 2000: Better outcome of severe hepatorenal syndrome after TIPS-insertion or vasoactive drugs? Analysis of phase-II data on seventy-six patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 126A

Daga, S.R. 2001: Better oxygenation in newborns without extra oxygen. Tropical Doctor 31(1): 58-59

Miller, S.A. 2000: Better pathogen detection and disease diagnosis through biotechnology. Phytopathology 90(6 Suppl): S109-S110

Chenzbraun, A.; Khoury, Z.; Gottlieb, S.; Goslitzer, T.; Keren, A. 2001: Better prediction of left atrial thrombus occurrence in atrial fibrillation patients by baseline cardiac pathology than by anticoagulation status. Journal of the American College of Cardiology 37(2 Suppl A): 445A-446A

Zareie, M.; Tangelder, G.J.; Terwee, P.M.; Van Lambalgen, A.A.; Keuning, E.D.; Beelen, R.H.J.; Van Den Born, J. 2003: Better preservation of peritoneal morphology and microcirculation in rats exposed to amino acid-based peritoneal dialysis fuid. Journal of the American Society of Nephrology 14(Abstracts Issue): 35A

Puttinger, H.; Dittrich, E.; Vonesh, E.; Horl, W.H. 2002: Better preservation of residual renal function with PD than HD/HDF. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 598A

Cafri, C.; Svirsky, R.; Gilutz, H.; Zelingher, J.; Ilia, R. 2001: Better procedural results in coronary thrombosis are obtained with delayed percutaneous coronary intervention. Journal of the American College of Cardiology 37(2 Suppl A): 34A

Krisper, P.; Rossler, A.; Holzer, H.; Schneditz, D. 2000: Better reduction of hyaluronic acid by hemodiafiltration does not influence HA predialysis levels. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 323A

Benigni, A.; Zoja, C.; Zatelli, C.; Corna, D.; Longaretti, L.; Rottoli, D.; Maggioni, P.; Todeschini, M.; Noris, M.; Remuzzi, G. 2003: Better renoprotection with vasopeptidase versus ACE inhibitors is related to their capacity of restoring renal ET-1/NO balance. Journal of the American Society of Nephrology 14(Abstracts Issue): 613A

Auer,M.R. 2010: Better science and worse diplomacy negotiating the cleanup of the Swedish and Finnish pulp and paper industry. International Environmental Agreements: Politics, Law And Economics: 1, 65-84

Kurtenkov, O.; Klaamas, K.; Sergeyev, B.; Miljukhina, L. 2003: Better survival of Helicobacter pylori seropositive patients with early gastric cancer is related to a higher level of antibodies to tumor-associated Thomson-Friedenreich antigen. Helicobacter 8(4): 426

Shah, M.R.; Shaw, L.; O'connor, C.M.; Califf, R.M. 2000: Better systolic function, but no better survival, for women with advance heart failure Findings from the Duke Databank for cardiovascular disease. Journal of the American College of Cardiology 35(2 Suppl A): 233A

Healy, H.; Cattell, D.; Tranter, R.; Jaffar, K.; Healy, D. 2000: Better than well on antidepressants. European Neuropsychopharmacology 10(Suppl 3): S261

Pascoe, P.J. 2003: Better therapies for everyday pain: exciting advances in pain management. Veterinary Journal 166(3): 215-217

Wenk, R.E.; Chiafari, F.A.; Gorlin, J.; Polesky, H.F. 2003: Better tools are needed for parentage and kinship studies. Transfusion 43(7): 979-981

Elit, L.; Gafni, A.; Levine, M.N. 2000: Better treatments that cost more: the dilemma. Gynecologic Oncology 78(1): 1-2

Queiroga, A.A.; Marshall, H.J.; Osman, F.; Gammage, M.D. 2001: Better understanding of the onset mechanisms of atrial fibrillation Optimizing selection of patients who may benefit from preventive pacing. Journal of the American College of Cardiology 37(2 Suppl A): 95A

Brandstetter, H.; Whittington, D.A.; Lippard, S.J.; Frederick, C.A. 1999: Better understanding of the soluble methane monooxygenase protein B structure through mutation and analysis. Journal of Inorganic Biochemistry 74(1-4): 337

Crippa, G.; Sverzellati, E.; Antoniotti, P.; Carrara, G.C. 2000: Bettering blood pressure control in clinical practice Role of ambulatory blood pressure monitoring. American Journal of Hypertension 13(4 Part 2): 218A

Gilbert, R. 2002: Betty Hobbs. Lancet (North American Edition) 360(9347): 1793

Aniskina, A.A. 1999: Betula fruticosa Pall as potential fodder plant of central area of Saha Republic. Rastitel'nye Resursy 35(1): 111-116

Guenthardt Goerg, M.S.; Kaelin, I.; Mathies, D. 1999: Betula pendula exposed to ozone Changes in young phloem and xylem cells of the stems. Journal of Experimental Botany 50(Suppl ): 35

Rubio, S.; Quintana, J.é; Eiroa, J.é L.; Triana, J.; Estévez, F. 2010: Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells. Molecular Carcinogenesis 49(1): 32-43

Debatin, K.M.; Fulda, S.; Wiessler, M.; Los, M.; Mier, W. 2002: Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)

Jaggi, M.; Ramadoss, S.; Rajendran, P.; Siddiqui, M.J.mshed Ahmad 2002: Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis. Official Gazette of the United States Patent and Trademark Office Patents 1259(2)

Swanson, S.M.; Cho, K.H.; Shin, Y.G.; Pezzuto, J.M.; Gupta, T.K.D.s 1999: Betulinic acid does not require metabolic activation to induce apoptosis in melanoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 488

Swanson, S.M.; Cho, K.H.; Chen, C.; Pezzuto, J.M.; Das Gupta, T.K. 2000: Betulinic acid induced cell death is independent of p53 in human melanoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 509

Paasch, U.; Dathe, S.; Grunewald, S.; Glander, H. 2004: Betulinic acid triggers disruption of mitochondrial membrane potential in ejaculated human spermatozoa. Archives of Dermatological Research 295(8-9): 334

Mullauer, F.B.; Kessler, J.H.; Medema, J.P. 2010: Betulinic acid, a natural compound with potent anticancer effects. Anti-Cancer Drugs 21(3): 215-227

Campisi, J. 2002: Between Scylla and Charybdis: p53 links tumor suppression and aging. Mechanisms of Ageing and Development 123(6): 567-573

Blumsohn, A.; Glueer, C.C.; Reid, D.M.; Felsenberg, D.; Roux, C.; Eastell, R. 2003: Between city differences in bone turnover, PTH and 25 D in the healthy female population Are common reference values justified?. Calcified Tissue International 72(4): 409

Neumann,P. 2010: Between competence and incompetence a comparison among different states concerning competence expectancies for physical education in elementary schools. Sportunterricht: 2, 35-41

Maganaris, C.N. 2002: Between muscles and movement Tendons and their properties in vivo. Journal of Physiology (Cambridge) 543P: 18S

Colgrove, J. 2004: Between persuasion and compulsion: Smallpox control in Brooklyn and New York, 1894-1902. Bulletin of the history of medicine 78(2): 349-378

Webster, B.; Gezan, S.; Bruce, T.; Hardie, J.; Pickett, J. 2010: Between plant and diurnal variation in quantities and ratios of volatile compounds emitted by Vicia faba plants. Phytochemistry 71(1): 81-89

Nimrod,G.; Rotem,A. 2010: Between relaxation and excitement activities and benefits gained in retirees tourism. International Journal Of Tourism Research: 1, 65-78

Tishelman, C. 2001: Between sickness and health? Nursing challenges in prevention and screening. European Journal of Cancer 37(Suppl 6): S399

Maureille, B.; Braga, J. 2002: Between the Incisive Bone and Prernaxilla From African Apes to Homo sapiens. Minugh-Purvis, Nancy , McNamara, Kenneth J Human evolution through developmental change 464-478

Nelson, N. 2002: Between the cracks Water law, land management policy and springs conservation in the United States. Ecological Society of America Annual Meeting Abstracts 87: 39

Mrozek, D.C.; Patel, R.R.; Wiviott, M.M.; Chorazy, J.P.; Novotny, M.; Gorelick, G.; Siegel, N.; Enevold, N.A. 1999: Between-assay reagent carryover testing on the Abbott ARCHITECT i2000 analyzer. Clinical Chemistry 45(6 Part 2): A6

Schifman, R.B.; James, S.H.; Sadrzadeh, S.M.H.; Rose, A.; Dick, S. 1999: Between-assay variation in false positive troponin-I measurements in patients on renal dialysis or with positive rheumatoid factor. Clinical Chemistry 45(6 Part 2): A145

Vanimisetti, H.B.; Greiner, S.P.; Zajac, A.M.; Notter, D.R. 2002: Between-breed variation in response to Haemonchus contortus infection in sheep. Journal of Dairy Science 85(Suppl 1): 148

Jennings, I.; Kitchen, S.; Smith, J.; Woods, T.A.L.; Preston, F.E. 2002: Between-centre agreement in homocysteine assays: experience from the UK NEQAS proficiency testing scheme. Thrombosis and Haemostasis 87(5): 921-922

Roy, D.K.; Pye, S.R.; Lunt, M.; O'neill, T.W.; Reeve, J.; Silman, A.J. 2001: Between-centre variation in limb fracture rates is due in part to variation in rates of falling. Journal of Bone and Mineral Research 16(Suppl 1): S391

Lobo, J.M.; Martin Piera, F. 1999: Between-group differences in the Iberian dung beetle species-area relationship. Acta Oecologica 20(6): 587-597

Leippert, D.; Goymann, W.; Hofer, H. 2000: Between-litter siblicide in captive Indian false vampire bats. Journal of Zoology (London) 251(4): 537-540

Sutton, J.M.; Cole, L.A.; Higgins, T.N.; Cembrowski, G.S. 2004: Between-method variation in hCG test results. Clinical Chemistry 50(6, Suppl S, Part 2): A91

Korenberg, J.R.; Barlow, G.M.; Person, T.; Jongewaard, I.N.; Klewer, S.E.; Runyan, R.B. 1999: Betwixt mouse and man A chick model of DS heart disease. American Journal of Human Genetics 65(4): A43

Sorbera, L.A.; Leeson, P.A.; Bayes, M. 2002: Bevacizumab Oncolytic. Drugs of the Future 27(7): 625-632

Goldberg, D.M.; Soleas, G.J. 2001: Beverage alcohol consumption as a negative risk factor for coronary heart disease Biochemical mechanisms. Agarwal, Dharam P , Reprint Author, Seitz, Helmut K Alcohol in health and disease: 547-572

Craig, J.J. 2000: Beverage analysis sample. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)

Swift, R.; Smoger, S.; Sexton, L.; Blondell, R.; Wieland, S.; Looney, S.W. 2000: Beverage and IV alcohol use in general hospitals. Alcoholism Clinical and Experimental Research 24(5 Suppl): 106A

Bech, Lene M.O.SlashedLskov; S.O.SlashedRensen, Steen Bech; Vaag, Pi; Muldbjerg, Marianne; Beenfeldt, Thorkild; Leah, Robert; Breddam, Klaus 1999: Beverage and a method of preparing it. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Martin, K.A.; Barr, T.L.igh 2003: Beverage and additive for the ill. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)

Zheng, Y.; Fu, X.; Sharkasi, T.Y.usef 2000: Beverage antioxidant system. Official Gazette of the United States Patent and Trademark Office Patents 1236(4)

Sulpizio, A. 2001: Beverage bag assembly for preparing hot or cold beverages. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)

Franklin, K.B.; Graham, S.T. 2000: Beverage beans and methods for their manufacture and use. Official Gazette of the United States Patent and Trademark Office Patents 1236(3)

Machover, J. 2004: Beverage bottle holder. Official Gazette of the United States Patent and Trademark Office Patents 1281(4)

Vancamp, R.E.; Warne, T.I. 1999: Beverage brewing apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Sargent, J.A.; Villagran, F.V. 2004: Beverage brewing devices for preparing creamy beverages. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)

Lassota, Z.G. 2003: Beverage brewing method with intermittent dispensing of beverage making liquid. Official Gazette of the United States Patent and Trademark Office Patents 1270(3)

Pascotti, J.; Apicelli, S.W. 2001: Beverage brewing press. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)

Kenny, R. 2004: Beverage can holder. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Kronseder, V.; Maschke, S.; Spindler, R. 2004: Beverage can with a protective cover, a blank for a protective cover, as well as a method and device for application of a protective cover to beverage cans. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)

Chargueraud, V.; Boukredine, E.; Blin, P. 2004: Beverage carton with strap type carrying handle. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)

Hale, R. 2004: Beverage cartridge and filter assembly. Official Gazette of the United States Patent and Trademark Office Patents 1288(1)

Mehansho, H.; Mellican, R.I.; Manchuso, S.E.; Nunes, R.V.; Spence, K.E. 2004: Beverage compositions comprising arabinogalactan and defined minerals. Official Gazette of the United States Patent and Trademark Office Patents 1280(2)

Nunes, R.V.; Elliott, E.G.; Trout, L.M.; Andon, M.B. 2003: Beverage compositions comprising palatable calcium and magnesium sources. Official Gazette of the United States Patent and Trademark Office Patents 1274(2)

Blumenstein Stahl, G.A.; Fischer, C.M.; Olbert, I. 2004: Beverage comprising an effective amount of flavanols as sweetness cutting composition. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Weaver, A.R.; Storey, M.L.; Woo, R.Y.; Clark, K.L. 2000: Beverage consumption among elementary and high school children. FASEB Journal 14(4): A534

Gardiner, James Lee 2004: Beverage container. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Bolts, L. 2003: Beverage container belt. Official Gazette of the United States Patent and Trademark Office Patents 1272(5)

Hashimoto, K. 2003: Beverage containing a kayu-like fermentation product. Official Gazette of the United States Patent and Trademark Office Patents 1276(1)

Lazaro Flores, C.; Calvo Lazaro, P.; Calvo Lazaro, E.; Manresa Ferrero, M.T.; Calvo Mondelo, F. 2001: Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity. Official Gazette of the United States Patent and Trademark Office Patents 1250(3)

Xiong, J. 2002: Beverage containing hybrid Rumex acetosa L and methods for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)

Moothart, M.J.; Aslin, D.R. 2004: Beverage cooling and dispensing device. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)

Greenberg, H.R. 2004: Beverage cooling device. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)

Sheridan, K.; Painter, I.N.; Finnegan, R.M.; Thorpe, M.; Chew, L.; Hamilton, D. 2004: Beverage dispenser. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)

Lassota, Z.G. 2004: Beverage dispenser with cover assembly and method. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)

Struminski, K.; Fisher, C.M. 2001: Beverage dispenser with syrup concentrate container. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)

Crisp, H.L.e IIi; Duff, T.E.ik 2004: Beverage dispensing apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1284(4)

Tobin, J.W.; Spisak, M.J. 2004: Beverage dispensing machine. Official Gazette of the United States Patent and Trademark Office Patents 1286(3)

Kibbe, A.J. 1999: Beverage dispensing system. Official Gazette of the United States Patent and Trademark Office Patents 1221(1)

Lassota, Z.G. 2003: Beverage dispensing urn with surface-covering member and method. Official Gazette of the United States Patent and Trademark Office Patents 1275(4)

Fukushima, N.; Mochida, Y.; Uehara, K. 2001: Beverage extraction apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1249(4)

Lazaris, N.G.; Beaulieu, R.H. 2003: Beverage filter cartridge holder. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)

Weiss, L. 2004: Beverage flow line cleaner with safety indicator and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1288(3)

Fuchs, N.; Wallner, R. 2003: Beverage for increasing the bodys capacity to break down alcohol and method thereof. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)

Zajac, G.W.; Gallas, J.M.; Panosh, R. 1999: Beverage freshness monitor. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)

Morello, M.J.; Franz, S.L. 2001: Beverage having L-ascorbic acid with stability of color and clarity. Official Gazette of the United States Patent and Trademark Office Patents 1250(2)

Hammond, C. 2001: Beverage infuser. Official Gazette of the United States Patent and Trademark Office Patents 1242(1)

Sandin, S.A. 2004: Beverage infusion device. Official Gazette of the United States Patent and Trademark Office Patents 1279(3)

Lassota, Z.G. 2003: Beverage ingredient filter and assembly. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)

Blum, J.W.; Beaudoin, C. 2003: Beverage intake, physical activity and bone mineral density in adolescent males. Medicine and Science in Sports and Exercise 35(5 Suppl): S325

Spisak, M.J.; Lehmberg, G.L. 2000: Beverage intermediate and method for coextracting tea leaves and other vegetable material. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Lassota, Z.G. 2004: Beverage maker with average dispense rate and volume control. Official Gazette of the United States Patent and Trademark Office Patents 1285(2)

Knepler, J.T. 2002: Beverage maker-funnel combination and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1263(3)

Haydon, James Andrew 2002: Beverage making apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)

Miller, P.E.; Lowrie, S.D. 1999: Beverage making apparatus with can piercer. Official Gazette of the United States Patent and Trademark Office Patents 1222(1)

Richter, F.L.; Cords, B.R.; Besse, M.E.; Nogami, K. 2001: Beverage manufacture and cold aseptic bottling using peroxyacid antimicrobial composition. Official Gazette of the United States Patent and Trademark Office Patents 1253(1)

Millard Stafford, M.L.; Sparling, P.B.; Rosskopf, L.B.; Baker, C.R.; Vandromme, M. 2003: Beverage osmolality No affect on fluid delivery in the heat. Medicine and Science in Sports and Exercise 35(5 Suppl): S311

Priley, A.P. 2001: Beverage preparation and layering device for an espresso machine. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Fond, O.; Pleisch, J.P.; Rossier, R.; Schaeffer, J.; Yoakim, A. 2000: Beverage preparation from a substance compacted into a cake. Official Gazette of the United States Patent and Trademark Office Patents 1231(3)

Fond, O.; Pleisch, J.P.; Rossier, R.; Schaeffer, J.; Yoakim, A. 2000: Beverage preparation from a substance compacted into a cake and contained in a sachet. Official Gazette of the United States Patent and Trademark Office Patents 1234(5)

Heczko, J. 2003: Beverage preparation system. Official Gazette of the United States Patent and Trademark Office Patents 1267(2)

Kearney, D.R.; Kirksey, S.T., J.; Cox, D.J. 2001: Beverage products having superior vitamin stability. Official Gazette of the United States Patent and Trademark Office Patents 1253(1)

Johnson, M.W.; Engler, C.J. 2001: Beverage quality control apparatus and method. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)

Borlinghaus, Axel Horst 2003: Beverage supply system. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)

Zeng, Xiaoqing Suzy 2004: Beverage system. Official Gazette of the United States Patent and Trademark Office Patents 1288(2)

Becker, Carl Meinhard 2004: Beverage tap. Official Gazette of the United States Patent and Trademark Office Patents 1282(3)

Jimenez Laguna, Antonio 1999: Beverage topping. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Mattes, R.D.; Rothacker, D.Q. 2001: Beverage viscosity is inversely related to post-ingestive hunger in humans. FASEB Journal 15(5): A980

Schub, A. 2004: Beverage whipping device. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)

Shamil, S.H. 1999: Beverage with reduction of lingering sweet aftertaste of sucralose. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)

Husz, Georg Bela 2001: Beverage, combination of concentrates and method for producing a beverage. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)

Schwenke, D.; Fehland, J.R.chard 2002: Beverage-filling device. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)

Chandler, K.P.; Richichi, U. 2002: Beverage-producing packages. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)

Elseviers, M.; Roper, H.W.lhelm Walter; Kobernick, H. 2001: Beverages for enhanced physical performance. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)

Keast, D.R.; Hoerr, S.L. 2004: Beverages most frequently consumed by youth, as reported using the FFQ compared to the 24-hour recall method, NHANES III. FASEB Journal 18(4-5): Abstract 35

White, A.S.; Godard, R.D.; Belling, C.; Kasza, V.; Beach, R.L. 2010: Beverages obtained from soda fountain machines in the U.S. contain microorganisms, including coliform bacteria. International Journal of Food Microbiology 137(1): 61-66

Villagran, F.V.; Butterbaugh, J.L.; Small, L.E.; Sargent, J.A. 2001: Beverages with improved texture and flavor impact at lower dosage of solids. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Ling, T.; Beck, M.H. 2003: Beware Atopic eczema may be complicated by allergic contact dermatitis to topical applications. British Journal of Dermatology 148(4): 847

Lubich, C.; Mrvos, R.; Krenzelok, E.P. 2003: Beware of canine Gorilla GlueTM ingestions A first report. Journal of Toxicology. Clinical Toxicology 41(5): 689

Hirschel, B. 2003: Beware of drug holidays before HIV salvage therapy. New England Journal of Medicine 349(9): 827-828

Kondo, Y.J.; Okutomi, T.; Hoka, S. 2002: Beware of gastric tube!. Anesthesia and Analgesia 95(4): 1122

L'Allemain, G. 2002: Beware of magic pills. Bulletin du Cancer 89(10): 835-836

Preston, R.F.; Gallagher, C.J.; Erali, M.D.; Kordik, C.; Luo, C.; Oldham, J.W.; Dufrain, R.J. 2001: Beware of positive results in an Ames screening assay when testing compounds at precipitated doses. Environmental and Molecular Mutagenesis 37(Suppl 32): 60

Baxter, A.; Mrvos, R.; Krenzelok, E.P. 2001: Beware of salicylism and herbal medicines. Journal of Toxicology. Clinical Toxicology 39(5): 549

Hirsch, L.J.; Claassen, J.; Emerson, R.G. 2002: Beware the SRPIDs Stimulus-responsive pseudoictal discharges are a common and important EEG pattern in critically ill patients. Epilepsia 43(Suppl 7): 283-284

Bouwhuis, S.A.; El Azhary, R.A.; Mcevoy, M.T.; Gibson, L.E.; Pittelkow, M.R. 2002: Bexarotene and T cell compartmentalization in CTCL. Journal of Investigative Dermatology 119(1): 244

Richardson, S.K.; Newton, S.B.; Budgin, J.B.; Benoit, B.; Bach, T.L.; Abrams, C.S.; Wysocka, M.; Rook, A.H. 2004: Bexarotene blunts trafficking of malignant T cells in Sezary syndrome reduction of CCR4-positive lymphocytes and decreased chernotaxis to TARC. Journal of Investigative Dermatology 122(3): A45

Talpur, R.; Ward, S.; Apisarnthanarax, N.; Duvic, M. 2001: Bexarotene combination therapy for cutaneous T-cell lymphoma. Journal of Investigative Dermatology 117(2): 535

Budgin, J.B.; Newton, S.; Richardson, S.K.; Benoit, B.; Urbiani, R.; Wysocka, M.; Rook, A.H. 2004: Bexarotene induces apoptosis of malignant T-cells purified from Sezary syndrome patients and inhibits IL-4 production variable susceptibility correlates with clinical response. Journal of Investigative Dermatology 122(3): A44

Zhang, C.; Hazarika, P.; Ni, X.; Duvic, M. 2001: Bexarotene regulates retinoid receptor and TIG-3 expression in cutaneous T-cell lymphoma lines but does not induce apoptosis. Journal of Investigative Dermatology 117(2): 525

Hanson, M.; Hill, A.; Duvic, M. 2003: Bexarotene reverses alopecia in cutaneous T-cell lymphoma. British Journal of Dermatology 149(1): 193-196

Zsolt, I. 2003: Bexarotene, a new option for the treatment of CTCL, approved by the FDA and the EMEA. Methods and Findings in Experimental and Clinical Pharmacology 25(Suppl A): 73

Breneman, D.; Sheth, P.; Stevens, V.; Hanifin, J. 2003: Bexarotene, a rexinoid, is anti-inflammatory in severe hand dermatitis. Inflammation Research 52(Suppl 2): S 108

Kaminski, M.S.; Zelenetz, A.; Leonard, J.; Saleh, M.; Jain, V. 2002: Bexxar Radioimmunotherapy Produces a Substantial Number of Durable Complete Responses in Patients with Multiply Relapsed or Refractory Low Grade or Transformed Low Grade Non-Hodgkins Lymphoma. Blood 100(11): Abstract No. 1382

Goldsmith, S.J.; Kostakoglu, L.; Wahl, R.; Alavi, A.; Divgi, C.; Hankins, J.; Zelenetz, A.; Kaminski, M. 2003: Bexxar is well tolerated and efficacious in heavily pretreated patients with non-Hodgkins lymphoma and mild thrombocytopenia. Journal of Nuclear Medicine 44(5 Suppl): 33P-34P

Harwood, S.J.; Rutar, F.; Sullivan, G.; Avlonitis, V. 2003: Bexxar radioimmunotherapy can be safely administered by health care professionals with minimal whole body exposure. Journal of Nuclear Medicine 44(5 Suppl): 327P

Wahl, R.L.; Goldsmith, S.; Kaminski, M.; Stewart, P.; Kroll, S. 2003: Bexxar radioimmunotherapy produces a meaningful therapeutic benefit in the form of durable responses of 5 years in patients with relapsed and refractory low grade-non-Hodgkins lymphoma. Journal of Nuclear Medicine 44(5 Suppl): 31P-32P

Davies, A.J.; Radford, J.A.; Rohatiner, A.Z.S.; Britton, K.; Owens, S.; Deakin, D.P.; Howell, S.; Carrington, B.M.; Lawrance, J.A.; Micallef, I.N.; Vinnicombe, S.; Clayton, J.; Matthews, J.; Harris, M.; Norton, A.; Lister, T.A. 2002: BexxarTM Over five years experience in two United Kingdom centres. British Journal of Cancer 86(Suppl 1): S26

Ali, A.; Kaminski, M.; Gregory, S.A.; Magnuson, D.; Wahl, R. 2001: BexxarTM is an effective and well tolerated therapy in elderly patients with non-Hodgkin lymphoma. Journal of Nuclear Medicine 42(5 Suppl): 156P

Micallef, I.; Radford, J.; Britten, K.; Owen, S.; Deakin, D.; Jan, H.; Foley, R.; Barlow, R.; Carrington, B.; Lawrance, J.; Vinnicombe, S.; Harris, M.; Norton, A.; Lister, A.; Rohatiner, A. 2000: BexxarTM radio immunotherapy for patients with B-cell non-Hodgkins lymphoma. British Journal of Cancer 83(Suppl 1): 16

Rosenberg, C.; Szuhai, K.; Bezrookove, V.; Raap, A.K.; Tanke, H.J. 2000: Beyond 24 colors-FISH Applications for cancer and clinical cytogenetics. European Journal of Human Genetics 8(Suppl 1): 38-39

Henry, A.A.; Romesberg, F.E. 2003: Beyond A, C, G and T: augmenting nature's alphabet. Current Opinion in Chemical Biology 7(6): 727-733

Orme, I.M. 1999: Beyond BCG: the potential for a more effective TB vaccine. Molecular Medicine Today 5(11): 487-492

Benner, S.A.; Chamberlin, S.G.; Govindarajan, S.; Knecht, L. 2000: Beyond BLAST Paleogenomics tools to infer function of genetic sequences. International Genome Sequencing and Analysis Conference 12: 29

Heim, D.; Geiser, F.; Perler, L.; Wyss, R. 2002: Beyond BSE Transmissible spongiform encephalopathies in other species. Schweizer Archiv für Tierheilkunde 144(12): 664-673

Siebert, S.F. 2003: Beyond Malthus and perverse incentives Economic globalization, forest conversion and habitat fragmentation. Bradshaw, G A , Reprint Author, Marquet, P A How landscapes change: Human disturbance and ecosystem fragmentation in the Americas: 19-32

Ede, N.J.; Wu, Z. 2003: Beyond Rf tagging. Current Opinion in Chemical Biology 7(3): 374-379

Stone, G.W.; Lansky, A.J.; Mehran, R.; Peterson, M.A.; Gruberg, L.; Dangas, G.; Eesai, K.; Slack, S.T.; Reed, R.; Proctor, B.; Leon, M.B. 2000: Beyond TIMI-3 flow The importance of restored myocardial perfusion for survival in high risk patients undergoing primary or rescue PTCA. Journal of the American College of Cardiology 35(2 Suppl A): 403A

Kaltoft, A.; Bottcher, M.; Sand, N.P.R.; Rehling, M.; Zjilstra, F.; Nielsen, T.T. 2002: Beyond TIMI-3 flow and myocardial blush Myocardial perfusion assessed by MPI immediately after primary percutaneous coronary intervention predicts final infarct size. European Heart Journal 23(Abstract Suppl): 717

Birnbaum, R. 2003: Beyond Title IV Perspectives on additional reductions. White, James C , Reprint Author Acid rain: Are the problems solved&Q: 35-39

Beavo, J. 2001: Beyond Viagra Other phosphodiesterases as targets for therapeutic intervention. AAAS Annual Meeting and Science Innovation Exposition 167: A54, February 15-20

Rovin, B.H. 2001: Beyond a glomerulocentric view of inflammation. Kidney International 60(2): 797-798

Georgianna, D.R.; Fedorova, N.D.; Burroughs, J.L.; Dolezal, A.L.; Bok, J.W.; Horowitz-Brown, S.; Woloshuk, C.P.; Yu, J.; Keller, N.P.; Payne, G.A. 2010: Beyond aflatoxin: four distinct expression patterns and functional roles associated with Aspergillus flavus secondary metabolism gene clusters. Molecular Plant Pathology 11(2): 213-226

Boersma, B.J.; Patel, R.; Kirk, M.; Darley Usmar, V.; Barnes, S. 1999: Beyond antioxidants The role of soy isoflavones in inflammation. Free Radical Biology and Medicine 27(Suppl 1): S32

Dobberteen, L.; Breen, S. 2003: Beyond bandaids A case-based interactive approach to teaching pediatric residents and medical students about school health. Pediatric Research 53(4 Part 2): 240A

Forrer, P.; Jung, S.; Plückthun, A. 1999: Beyond binding: using phage display to select for structure, folding and enzymatic activity in proteins. Current Opinion in Structural Biology 9(4): 514-520

Lee, K.E.; Klein, B.E.K.; Klein, R. 2000: Beyond blood pressure and cholesterol Hematologic and serum factors associated with cardiovascular mortality. American Journal of Epidemiology 151(11 Suppl): S36

Weintraub, H.S. 2002: Beyond blood pressure effects of AII blockade. American Journal of Hypertension 15(4 Part 2): 238A

Swords, Kathy, M.M. 1999: Beyond breeding Pest-resistant plants and public perception. Trends in Biotechnology 17(7): 261-262

Klein, D.E. 2004: "Beyond 'broke'": three steps to improve how your hospital buys, uses, and repairs equipment. Biomedical Instrumentation and Technology 38(3): 197-200

Romanowski, E.G.; Yates, K.A.; Heiry, M.; Gordon, Y.J. 2001: Beyond cidofovir The in vitro evaluation of newer potential antiviral agents against ocular isolates of adenovirus. IOVS Investigative Ophthalmology and Visual Science 42(4): S579

Kershen, R.T.; Dmochowski, R.R.; Appell, R.A. 2002: Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urologic Clinics of North America 29(3): 559-574

Knetter, S.J.; Mathews, N.E. 2001: Beyond composition Incorporating landscape pattern into gap analysis distribution models. Ecological Society of America Annual Meeting Abstracts 86: 303-304

Breyer, M.D. 2002: Beyond cyclooxygenase. Kidney International 62(5): 1898-1899

Farag, W. 2002: Beyond data DiBase bridges the information gap Getting the picture, not the pixels. Molecular and Cellular Proteomics 1(9): 720

Patel, P.; Gayle, Y. 1999: Beyond dispensing Individualized pharmaceutical interventions to improve hospitalized elder care. Journal of the American Geriatrics Society 47(9): S35

Cerami, A. 2001: Beyond erythropoiesis: novel applications for recombinant human erythropoietin. Seminars in Hematology 38(3 Suppl 7: 33-39

Casadesus, G.; Zhu, X.; Atwood, C.S.; Webber, K.M.; Perry, G.; Bowen, R.L.; Smith, M.A. 2004: Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. Current Drug Targets. Cns and Neurological Disorders 3(4): 281-285

Kadlec, H.; van Rooij, I. 2003: Beyond existence: inferences about mental processes from reversed associations. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 39(1): 183-187

Bondos, S.E.; Bicknell, A. 2003: Beyond genetics How to purify soluble protein. Developmental Biology 259(2): 574

Ramos, K.S.; Walker, C.L. 2003: Beyond genomics Image analysis and computational biology. Toxicological Sciences 72(S-1): 223

Fischer, O.M.; Streit, S.; Hart, S.; Ullrich, A. 2003: Beyond Herceptin and Gleevec. Current Opinion in Chemical Biology 7(4): 490-495

Drapeau, M.D. 2001: Beyond heritability: the future of behavioral genetics. Trends in Genetics: Tig 17(10): 561-562

Cao, Y.anning; Kitamura, Kazuo; Kato, Johji; Kuwasako, Kenji; Tsuruda, Toshihiro; Chen, Alex; Eto, Tanenao 2003: Beyond hypotensive effect, the antioxidant effect of adrenomedullin in Dahl salt-sensitive rat. Free Radical Biology and Medicine 35(Suppl 1): S116

Lencucha, R.; Labonté, R.; Rouse, M.J. 2010: Beyond idealism and realism: Canadian NGO/government relations during the negotiation of the FCTC. Journal of Public Health Policy 31(1): 74-87

Ridgely, R.; Witmer, L.M. 2004: Beyond imaging Using 3D-datasets in comparative morphology. Journal of Morphology 260(3): 321-322

Stidham, M.A. 2002: Beyond imidazolinones Herbicides of the new millenium. Abstracts of Papers American Chemical Society 224(1-2): AGRO 15

Kimby, E. 2002: Beyond immunochemotherapy Combinations of rituximab with cytokines interferon-alpha2a and granulocyte-macrophage colony stimulating factor. Seminars in Oncology 29(2 Suppl 6): 7-10

Goetghebeur, E.; Loeys, T. 2002: Beyond intention to treat. Epidemiologic Reviews 24(1): 85-90

Treiber, D.K.; Williamson, J.R. 2001: Beyond kinetic traps in RNA folding. Current Opinion in Structural Biology 11(3): 309-314

Portmann, M.; Carpenter, C.; Mcguirk, B.; Feinberg, R. 2003: Beyond laboratory testing Data collection serves important practice management functions. Fertility and Sterility 80(Suppl 3): S300

Arsenault, B.J.; Rana, J.S.; Stroes, E.S.G.; Després, J.-P.; Shah, P.K.; Kastelein, J.J.P.; Wareham, N.J.; Boekholdt, S.M.; Khaw, K.-T. 2009: Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Journal of the American College of Cardiology 55(1): 35-41

Brochu, C.A. 2000: Beyond mere morphology Reflections of a computed tomography addict. American Zoologist 40(6): 955

Shepanek, R.F.; Frithsen, J. 1999: Beyond metadata Scientific information management approaches supporting ecosystem monitoring and assessment activities. Kaser, R T Metadiversity: The grand challenge for biodiversity information management through metadata: The call for community 89-95

O'malley, K.; Banks, M. 2003: Beyond microsatellites for better discrimination among endangered chinook salmon. American Fisheries Society Annual Meeting 133: 56

Cunningham, M.R.; Shamblen, S.R. 2003: Beyond nature versus culture A multiple fitness analysis of variations in grooming. Voland, Eckart , Reprint Author, Grammer, Karl Evolutionary aesthetics: 201-237

Sühnel, J. 2001: Beyond nucleic acid base pairs: from triads to heptads. Biopolymers 61(1): 32-51

Rocha Lima, C.M.; Urbanic, J.J.; Lal, A.; Kneuper-Hall, R.; Brunson, C.Y.; Green, M.R. 2001: Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. Seminars in Oncology 28(3 Suppl. 10): 34-43

Schaefer, M. 2001: Beyond park boundaries The broader value of park-based research. AAAS Annual Meeting and Science Innovation Exposition 167: A29, February 15-20

Berns, G.S. 2000: Beyond phrenology Using functional MRI to study brain dynamics. European Neuropsychopharmacology 10(Suppl 3): S180

Gonsalves, C.V.; Lee, D.R.; Gonsalves, D. 2000: Beyond plant pathology Socioeconomic impact of transgenic virus-resistant papayas on the Hawaii papaya farmers. Phytopathology 90(6 Suppl): S29

Potvin, L.; Haddad, S.; Frohlich, K.L. 2001: Beyond process and outcome evaluation: a comprehensive approach for evaluating health promotion programmes. Who Regional Publications. European Series 2001(92): 45-62

Dejgaard, K.; Jansen, G.; Pollock, S.; Theberge, J.F.; Thomas, D.Y. 2003: Beyond proteomics Protein interactomics. Molecular and Cellular Proteomics 2(9): 693

Quinn, P.C. 2002: Beyond prototypes: asymmetries in infant categorization and what they teach us about the mechanisms guiding early knowledge acquisition. Advances in Child Development and Behavior 29: 161-193

Preston, C.M.; Trofymow, J.A. 1999: Beyond proximate analysis Development of litter quality indices from solid-state carbon-13 CPMAS NMR spectroscopy. Canadian Journal of Soil Science 79(4): 648

Mann, J.J. 2001: Beyond prozac Mechanisms of action of antidepressants. AAAS Annual Meeting and Science Innovation Exposition 167: A54, February 15-20

Ali, A.; Hashem, M.; Rehan, A.; Nayugavan, R.; Michael, J.; Lalond, T.; Pieper, D. 2000: Beyond randomized trials Safety of platelet glycoprotein IIb/IIIa receptor antagonists in real life. Circulation 102(18): 2; 666